AMETEK (AME) 10-K 20 Feb 25 2024 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2024	Jan. 31, 2025	Jun. 30, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2024
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	1-12981
Entity Registrant Name	AMETEK, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	14-1682544
Entity Address, Address Line One	1100 Cassatt Road
Entity Address, City or Town	Berwyn
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19312-1177
City Area Code	610
Local Phone Number	647-2121
Title of 12(b) Security	Common Stock, $0.01 Par Value
Trading Symbol	AME
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 38.6
Entity Common Stock, Shares Outstanding		230,659,382
Documents Incorporated by Reference	Documents Incorporated by Reference
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Entity Central Index Key	0001037868

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Audit Information [Abstract]
Auditor Name	ERNST & YOUNG LLP
Auditor Location	Philadelphia, Pennsylvania
Auditor Firm ID	42

Consolidated Statement of Incom

Consolidated Statement of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net sales	$ 6,941,180	$ 6,596,950	$ 6,150,530
Cost of sales	4,464,713	4,212,485	4,005,261
Selling, general and administrative	696,905	677,006	644,577
Total operating expenses	5,161,618	4,889,491	4,649,838
Operating income	1,779,562	1,707,459	1,500,692
Interest expense	(112,962)	(81,795)	(83,186)
Other (expense) income, net	(5,061)	(19,252)	11,186
Income before Income Taxes	1,661,539	1,606,412	1,428,692
Provision for income taxes	285,415	293,224	269,150
Net income	$ 1,376,124	$ 1,313,188	$ 1,159,542
Basic earnings per share (in USD per share)	$ 5.95	$ 5.70	$ 5.04
Diluted earnings per share (in USD per share)	$ 5.93	$ 5.67	$ 5.01
Weighted average common shares outstanding:
Basic shares (in shares)	231,256	230,519	230,208
Diluted shares (in shares)	232,168	231,509	231,536

Consolidated Statement of Compr

Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 1,376,124	$ 1,313,188	$ 1,159,542
Foreign currency translation:
Translation adjustments	(124,959)	88,613	(123,756)
Change in long-term intercompany notes	(2,748)	5,420	(21,419)
Net investment hedge instruments gain (loss), net of tax of $(11,207), $8,058 and ($17,070) in 2024, 2023 and 2022, respectively	34,409	(24,744)	52,416
Defined benefit pension plans:
Net actuarial gain (loss), net of tax of $(4,936), $(3,396) and $4,769 in 2024, 2023 and 2022, respectively	15,145	11,869	(18,238)
Amortization of net actuarial loss, net of tax of ($2,341), ($2,801) and ($2,111) in 2024, 2023 and 2022, respectively	7,278	8,769	6,420
Amortization of prior service costs, net of tax of $(26), ($25) and ($25) in 2024, 2023 and 2022, respectively	78	76	76
Other comprehensive (loss) income	(70,797)	90,003	(104,501)
Total comprehensive income	$ 1,305,327	$ 1,403,191	$ 1,055,041

Consolidated Statement of Com_2

Consolidated Statement of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Tax benefit (expense) from investment hedge instruments	$ (11,207)	$ 8,058	$ (17,070)
Tax benefit (expense) from change in pension plans	(4,936)	(3,396)	4,769
Tax related to amortization of net actuarial loss	(2,341)	(2,801)	(2,111)
Tax related to amortization of prior service costs	$ (26)	$ (25)	$ (25)

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 373,999	$ 409,804
Receivables	948,830	1,012,932
Inventories, net	1,021,713	1,132,471
Other current assets	258,490	269,461
Total current assets	2,603,032	2,824,668
Property, plant and equipment, net	818,611	891,293
Right of use assets, net	235,666	229,723
Goodwill	6,555,877	6,447,629
Other intangibles, net	3,915,173	4,165,317
Investments and other assets	502,810	464,903
Total assets	14,631,169	15,023,533
Current liabilities:
Short-term borrowings and current portion of long-term debt, net	654,346	1,417,915
Accounts payable	523,332	516,588
Customer advanced payments	363,555	375,513
Income taxes payable	84,428	69,567
Accrued liabilities and other	472,926	502,990
Total current liabilities	2,098,587	2,882,573
Long-term debt, net	1,425,375	1,895,432
Deferred income taxes	831,030	836,695
Other long-term liabilities	620,873	678,642
Total liabilities	4,975,865	6,293,342
Stockholders’ equity:
Preferred stock,$0.01 par value; authorized 5,000,000 shares; none issued	0	0
Common stock, $0.01 par value; authorized 800,000,000 shares; issued: 2024 – 270,064,222 shares; 2023 – 269,284,250 shares	2,720	2,709
Capital in excess of par value	1,264,670	1,168,694
Retained earnings	11,057,684	9,940,343
Accumulated other comprehensive loss	(555,739)	(484,942)
Treasury stock: 2024 – 39,364,801 shares; 2023 – 38,354,154 shares	(2,114,031)	(1,896,613)
Total stockholders’ equity	9,655,304	8,730,191
Total liabilities and stockholders’ equity	$ 14,631,169	$ 15,023,533

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parenthetical) - $ / shares	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	800,000,000	800,000,000
Common stock, shares issued	270,064,222	269,284,250
Treasury stock, shares	39,364,801	38,354,154

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Total	Capital stock	Capital in excess of par value	Retained earnings	Foreign currency translation:	Defined benefit pension plans:	Accumulated other comprehensive loss income	Treasury stock
Balance at the beginning of the year at Dec. 31, 2021		$ 2,689	$ 1,012,526	$ 7,900,113	$ (275,365)	$ (195,079)		$ (1,573,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued		11
Issuance of common stock under employee stock plans			34,335					2,857
Share-based compensation costs			47,375
Net income	$ 1,159,542			1,159,542
Cash dividends paid				(202,169)
Other				(1)
Translation adjustments	(123,756)				(123,756)
Change in long-term intercompany notes					(21,419)
Net investment hedge instruments (loss) gain, net of tax of $(11,207), $8,058 and ($17,070) in 2024, 2023 and 2022, respectively					52,416
Net actuarial gain (loss), net of tax of $(4,936), $(3,396) and $4,769 in 2024, 2023 and 2022, respectively	(18,238)					(18,238)
Amortization of net actuarial loss, net of tax of ($2,341), ($2,801) and ($2,111) in 2024, 2023 and 2022, respectively	6,420					6,420
Amortization of prior service costs, net of tax of $(26), ($25) and ($25) in 2024, 2023 and 2022, respectively	76					76
Purchase of treasury stock								(332,821)
Balance at the end of the year at Dec. 31, 2022	7,476,512	2,700	1,094,236	8,857,485	(368,124)	(206,821)	$ (574,945)	(1,902,964)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued		9
Issuance of common stock under employee stock plans			28,259					14,123
Share-based compensation costs			46,199
Net income	1,313,188			1,313,188
Cash dividends paid				(230,329)
Other				(1)
Translation adjustments	88,613				88,613
Change in long-term intercompany notes					5,420
Net investment hedge instruments (loss) gain, net of tax of $(11,207), $8,058 and ($17,070) in 2024, 2023 and 2022, respectively					(24,744)
Net actuarial gain (loss), net of tax of $(4,936), $(3,396) and $4,769 in 2024, 2023 and 2022, respectively	11,869					11,869
Amortization of net actuarial loss, net of tax of ($2,341), ($2,801) and ($2,111) in 2024, 2023 and 2022, respectively	8,769					8,769
Amortization of prior service costs, net of tax of $(26), ($25) and ($25) in 2024, 2023 and 2022, respectively	76					76
Purchase of treasury stock	(7,800)							(7,772)
Balance at the end of the year at Dec. 31, 2023	8,730,191	2,709	1,168,694	9,940,343	(298,835)	(186,107)	(484,942)	(1,896,613)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued		11
Issuance of common stock under employee stock plans			48,113					5,654
Share-based compensation costs			47,863
Net income	1,376,124			1,376,124
Cash dividends paid				(258,782)
Other				(1)
Translation adjustments	(124,959)				(124,959)
Change in long-term intercompany notes					(2,748)
Net investment hedge instruments (loss) gain, net of tax of $(11,207), $8,058 and ($17,070) in 2024, 2023 and 2022, respectively					34,409
Net actuarial gain (loss), net of tax of $(4,936), $(3,396) and $4,769 in 2024, 2023 and 2022, respectively	15,145					15,145
Amortization of net actuarial loss, net of tax of ($2,341), ($2,801) and ($2,111) in 2024, 2023 and 2022, respectively	7,278					7,278
Amortization of prior service costs, net of tax of $(26), ($25) and ($25) in 2024, 2023 and 2022, respectively	78					78
Purchase of treasury stock	(223,100)							(223,072)
Balance at the end of the year at Dec. 31, 2024	$ 9,655,304	$ 2,720	$ 1,264,670	$ 11,057,684	$ (392,133)	$ (163,606)	$ (555,739)	$ (2,114,031)

Consolidated Statement of Sto_2

Consolidated Statement of Stockholders' Equity (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Tax benefit (expense) from investment hedge instruments	$ (11,207)	$ 8,058	$ (17,070)
Tax benefit (expense) from change in pension plans	(4,936)	(3,396)	4,769
Tax related to amortization of net actuarial loss	(2,341)	(2,801)	(2,111)
Tax related to amortization of prior service costs	$ (26)	$ (25)	$ (25)

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating activities:
Net income	$ 1,376,124	$ 1,313,188	$ 1,159,542
Adjustments to reconcile net income to total operating activities:
Depreciation and amortization	382,927	337,636	319,427
Deferred income taxes	(12,943)	(91,903)	(67,818)
Share-based compensation expense	47,863	46,199	47,375
Gain on sale of business/investment	0	0	(3,584)
Gain on sale of facilities	(995)	(120)	(7,054)
Changes in assets and liabilities, net of acquisitions:
Decrease (increase) in receivables	53,488	8,451	(86,713)
Decrease (increase) in inventories and other current assets	72,997	56,619	(322,467)
(Decrease) increase in payables, accruals and income taxes	(18,480)	10,433	95,481
(Decrease) increase in other long-term liabilities	(41,332)	67,283	47,226
Pension contributions	(8,694)	(8,671)	(8,959)
Other, net	(22,107)	(3,819)	(23,083)
Total operating activities	1,828,848	1,735,296	1,149,373
Investing activities:
Additions to property, plant and equipment	(127,075)	(136,249)	(139,005)
Purchases of businesses, net of cash acquired	(117,514)	(2,237,910)	(429,714)
Proceeds from sale of business/investment	0	0	3,734
Proceeds from sale of facilities	4,246	880	11,754
Other, net	(4,465)	(3,151)	471
Total investing activities	(244,808)	(2,376,430)	(552,760)
Financing activities:
Net change in short-term borrowings	(889,737)	892,282	(73,691)
Repayments of long-term borrowings	(300,000)	0	0
Repurchases of common stock	(212,027)	(7,772)	(332,821)
Cash dividends paid	(258,782)	(230,329)	(202,169)
Proceeds from stock option exercises	66,868	50,850	49,937
Other, net	(8,776)	(7,748)	(16,955)
Total financing activities	(1,602,454)	697,283	(575,699)
Effect of exchange rate changes on cash and cash equivalents	(17,391)	8,269	(22,300)
(Decrease) increase in cash and cash equivalents	(35,805)	64,418	(1,386)
Cash and cash equivalents:
Beginning of year	409,804	345,386	346,772
End of year	$ 373,999	$ 409,804	$ 345,386

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Consolidation The accompanying consolidated financial statements reflect the results of operations, financial position and cash flows of AMETEK, Inc. (the “Company”), and include the accounts of the Company and subsidiaries, after elimination of all intercompany transactions in the consolidation. Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates and assumptions. Cash Equivalents, Securities and Other Investments All highly liquid investments with maturities of three months or less when purchased are considered cash equivalents. Accounts Receivable The Company maintains allowances for estimated credit losses resulting from the inability of customers to meet their financial obligations to the Company. The Company recognizes an allowance for credit losses, on all accounts receivable and contract assets, which considers risk of future credit losses based on factors such as historical experience, contract terms, as well as general and market business conditions, country, and political risk. Balances are written off when considered uncollectible. The following table provides a roll forward of the allowance for estimated credit losses: 2024 2023 (in thousands) Balance at January 1 $ 13,167 $ 14,102 Bad debt expense 2,546 3,984 Amounts written off charged against allowance (2,506) (4,908) Foreign currency translation and other (175) (11) Balance at December 31 $ 13,032 $ 13,167 Inventories The Company predominantly uses the first-in, first-out (“FIFO”) method of inventory accounting, which approximates current replacement cost, at December 31, 2024. The last-in, first-out (“LIFO”) method of accounting is used to determine cost for 10% of the Company’s inventory at December 31, 2024. For inventories where cost is determined by the LIFO method, the FIFO value would have been $40.8 million and $39.0 million higher than the LIFO value reported in the consolidated balance sheet at December 31, 2024 and 2023, respectively. The Company provides estimated inventory reserves for slow-moving and obsolete inventory based on current assessments about future demand, market conditions, customers who may be experiencing financial difficulties and related management initiatives. Business Combinations The Company allocates the purchase price of an acquired company, including when applicable, the acquisition date fair value of contingent consideration between tangible and intangible assets acquired and liabilities assumed from the acquired business based on their estimated fair values, with the residual of the purchase price recorded as goodwill. The results of operations of the acquired business are included in the Company’s operating results from the date of acquisition. Property, Plant and Equipment Property, plant and equipment are stated at cost. Expenditures for additions to plant facilities, or that extend their useful lives, are capitalized. The cost of minor tools, jigs and dies, and maintenance and repairs is charged to expense as incurred. Depreciation of plant and equipment is calculated principally on a straight-line basis over the estimated useful lives of the related assets. The range of lives for depreciable assets is generally three five Goodwill and Other Intangible Assets Goodwill and other intangible assets with indefinite lives, primarily trademarks and trade names, are not amortized; rather, they are tested for impairment at least annually. The Company identifies its reporting units at the component level, which is one level below its operating segments. Generally, goodwill arises from acquisitions of specific operating companies and is assigned to the reporting unit in which the operating company resides. The Company’s reporting units are divisions that are one level below its operating segments and for which discrete financial information is prepared and regularly reviewed by segment management. The Company principally relies on a discounted cash flow analysis to determine the fair value of each reporting unit, which considers cash flows discounted at an appropriate discount rate. The Company believes that market participants would use a discounted cash flow analysis to determine the fair value of its reporting units in a sale transaction. The annual goodwill impairment test requires the Company to make a number of assumptions and estimates concerning future levels of revenue growth, operating margins, depreciation, amortization and working capital requirements, which are based on the Company’s long-range plan and are considered level 3 inputs. The Company's long-range plan is updated as part of its annual planning process and is reviewed and approved by management. The discount rate is an estimate of the overall after-tax rate of return required by a market participant whose weighted average cost of capital includes both equity and debt, including a risk premium. The impairment test for indefinite-lived intangibles other than goodwill (primarily trademarks and trade names) consists of a comparison of the estimated fair value of the indefinite-lived intangible asset to the carrying value of the asset as of the impairment testing date. The Company estimates the fair value of its indefinite-lived intangibles using the relief from royalty method using level 3 inputs for revenue growth rates and royalty rates. The fair value derived from the relief from royalty method is measured as the discounted cash flow savings realized from owning such trademarks and trade names and not having to pay a royalty for their use. The Company completed its required annual impairment tests as of October 1, 2024, 2023, and 2022 and determined that the carrying values of the Company's goodwill were not impaired. The Company completed its required annual indefinite-lived intangibles impairment test as of October 1, 2024 and determined that the carrying values of the Company's trademarks and trade names with indefinite lives were not impaired. The Company completed its required annual impairment test in the fourth quarter of 2023 and 2022 and determined that the carrying values of certain of the Company's trademarks and trade names with indefinite lives were impaired and as a result, during the fourth quarter of 2023 and 2022, the Company recorded an immaterial non-cash impairment charge related to certain of the Company's trade names. Other intangible assets with finite lives are evaluated for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of other intangible assets with finite lives is considered impaired when the total projected undiscounted cash flows from the asset group are less than the carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of those assets. Fair value is determined primarily using present value techniques based on projected cash flows from the asset group. Intangible assets, other than goodwill, with definite lives are amortized over their estimated useful lives. Patents and technology are being amortized over useful lives of nine ten Financial Instruments and Foreign Currency Translation Assets and liabilities of foreign operations are translated using exchange rates in effect at the balance sheet date and their results of operations are translated using average exchange rates for the year. Certain transactions of the Company and its subsidiaries are denominated in currencies other than their functional currency. Exchange gains and losses from those transactions are included in operating results for the year. The Company makes infrequent use of derivative financial instruments. Forward contracts are primarily entered into from time to time to hedge debt or foreign currency transactions, thereby minimizing the Company’s exposure to foreign currency fluctuation. In instances where transactions are designated as hedges of an underlying item, the gains and losses on those transactions are included in accumulated other comprehensive income within stockholders’ equity to the extent they are effective as hedges. An evaluation of hedge effectiveness is performed by the Company at inception and on an ongoing basis and any changes in the hedge are made as appropriate. Leases The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. The Company has lease agreements which include lease and non-lease components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable. Operating leases are included in right-of-use ("ROU") assets, accrued liabilities and other, and other long-term liabilities on our consolidated balance sheets. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company primarily leases buildings (real estate) and automobiles which are classified as operating leases. The lease term for all of the Company’s leases includes the non-cancellable period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company’s leases as the reasonably certain threshold is not met. Lease payments included in the measurement of the lease liability are comprised of fixed and variable payments that depend on an index or rate. Variable lease payments not dependent on a rate or index associated with the Company’s leases are recognized when the events, activities, or circumstances in the lease agreement on which those payments are assessed are probable. Variable lease payments are presented as operating expense in the Company’s income statement in the same line item as expense arising from fixed lease payments. Cash used in operations for operating leases is not materially different than total lease costs. Revenue Recognition Revenue is derived from sales of products and services. The Company’s products and services are marketed and sold worldwide through two operating groups: EIG and EMG. See Note 15 Descriptive Information about Reportable Segments. The majority of the Company’s revenues on product sales were recognized at a point in time when the customer obtains control of the product. The transfer in control of the product to the customer was typically evidenced by one or more of the following: the customer having legal title to the product, the Company’s present right to payment, the customer’s physical possession of the product, the customer accepting the product, or the customer having the benefits of ownership or risk of loss. For a small percentage of sales where title and risk of loss transfers at the point of delivery, the Company recognized revenue upon delivery to the customer, which is the point that control transferred, assuming all other criteria for revenue recognition were met. The Company determined that revenues from certain of its customer contracts met the criteria of satisfying its performance obligations over time, primarily in the areas of the manufacture of custom-made equipment and for service repairs of customer-owned equipment. Recognizing revenue over time for custom-manufactured equipment is based on the Company’s judgment that, in certain contracts, the product does not have an alternative use and the Company has an enforceable right to payment for performance completed to date. The Company recognizes incremental cost of obtaining contracts as an expense when incurred if the amortization period of the contract cost assets that the Company would have otherwise recognized is one year or less. These costs are included in Selling, general and administrative expenses in the consolidated statement of income. The determination of the revenue to be recognized in each period for performance obligations satisfied over time is based on the input method. The Company recognizes revenue over time as it performs on these contracts because the transfer of control to the customer occurs over time. Revenue is recognized based on the extent of progress towards completion of the performance obligation. The Company generally uses the total cost-to-cost input method of progress because it best depicts the transfer of control to the customer that occurs as costs are incurred. Under the cost-to-cost method, the extent of progress towards completion is measured based on the proportion of costs incurred to date to the total estimated costs at completion of the performance obligation. On certain contracts, labor hours are used as the measure of progress when it is determined to be a better depiction of the transfer of control to the customer due to the timing and pattern of labor hours incurred. Performance obligations also include post-delivery service, installation and training. Post-delivery service revenues are recognized over the contract term. Installation and training revenues are recognized over the period the service is provided. Warranty terms in customer contracts can also be considered separate performance obligations if the warranty provides services beyond assurance that a product complies with agreed-upon specification or if a warranty can be purchased separately. The Company does not incur significant obligations for customer returns and refunds. The Company has certain contracts with variable consideration in the form of volume discounts, rebates and early payment options, which may affect the transaction price used as the basis for revenue recognition. Payment terms generally begin upon shipment of the product. The Company does have contracts with multiple billing terms that are all due within one year from when the product is delivered. No significant financing component exists. Payment terms are generally 30-60 days from the time of shipment or customer acceptance, but terms can be shorter or longer, not exceeding one year. For customer contracts that have revenue recognized over time, revenue is generally recognized prior to a payment being due from the customer. In such cases, the Company recognizes a contract asset at the time the revenue is recognized. When payment becomes due based on the contract terms, the Company reduces the contract asset and records a receivable. In contracts with billing milestones or in other instances with a long production cycle or concerns about credit, customer advance payments are received. The Company may receive a payment in excess of revenue recognized to that date. In these circumstances, a contract liability is recorded. Contract liabilities are derecognized when the performance obligations are satisfied, and revenue is recognized. Research and Development Research and development costs are included in Cost of sales as incurred and were $236.6 million in 2024, $220.8 million in 2023 and $198.8 million in 2022. Shipping and Handling Costs Shipping and handling costs are included in Cost of sales and were $87.6 million in 2024, $77.9 million in 2023 and $103.7 million in 2022. Share-Based Compensation The Company expenses the fair value of share-based awards made under its share-based plans in the consolidated financial statements over their requisite service period of the grants. Income Taxes The Company conducts a broad range of operations around the world and is therefore subject to complex tax regulations in numerous international taxing jurisdictions, resulting at times in tax audits, disputes and potential litigation, the outcome of which is uncertain. Management must make judgments currently about such uncertainties and determine estimates of the Company’s tax assets and liabilities. To the extent the final outcome differs, future adjustments to the Company’s tax assets and liabilities may be necessary. The Company assesses the realizability of its deferred tax assets, taking into consideration the Company’s forecast of future taxable income, available net operating loss carryforwards and available tax planning strategies that could be implemented to realize the deferred tax assets. Based on this assessment, management must evaluate the need for, and amount of, valuation allowances against the Company’s deferred tax assets. The Company assesses the uncertainty in its tax positions, by applying a minimum recognition threshold which a tax position is required to meet before a tax benefit is recognized in the financial statements. Once the minimum threshold is met, using a more likely than not standard, a series of probability estimates is made for each item to properly measure and record a tax benefit. The tax benefit recorded is generally equal to the highest probable outcome that is more than 50% likely to be realized after full disclosure and resolution of a tax examination. The underlying probabilities are determined based on the best available objective evidence such as recent tax audit outcomes, published guidance, external expert opinion, or by analogy to the outcome of similar issues in the past. There can be no assurance that these estimates will ultimately be realized given continuous changes in tax policy, legislation and audit practice. The Company recognizes interest and penalties accrued related to uncertain tax positions in income tax expense. Pensions The Company has U.S. and foreign defined benefit and defined contribution pension plans. The key assumptions in determining the Company’s pension income or expense are the assumed pension liability discount rate and the expected return on plan assets. All unrecognized prior service costs, remaining transition obligations or assets and actuarial gains and losses have been recognized, net of tax effects, as a charge to accumulated other comprehensive income in stockholders’ equity and will be amortized as a component of net periodic pension cost. The Company uses a measurement date of December 31 (its fiscal year end) for its U.S. and foreign defined benefit plans. Earnings Per Share The calculation of basic earnings per share is based on the weighted average number of common shares considered outstanding during the periods. The calculation of diluted earnings per share reflects the effect of all potentially dilutive securities (principally outstanding stock options and restricted stock grants). The number of weighted average shares used in the calculation of basic earnings per share and diluted earnings per share was as follows for the years ended December 31: 2024 2023 2022 (In thousands) Weighted average shares: Basic shares 231,256 230,519 230,208 Equity-based compensation plans 912 990 1,328 Diluted shares 232,168 231,509 231,536 The calculation of diluted earnings per share for 2022 excluded an immaterial number of stock options because the exercise prices of these stock options exceeded the average market price of the Company’s common shares, and the effect of their inclusion would have been antidilutive. There were no antidilutive shares in 2024 and 2023.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	12 Months Ended
	Dec. 31, 2024
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements Recently Adopted Accounting Pronouncement In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which requires disclosure of significant segment expenses and other segment items on an annual and interim basis under ASC 280. The Company retrospectively adopted ASU 2023-07, effective December 31, 2024, and the adoption resulted in additional disclosures in the Reportable Segments footnote. Recent Accounting Pronouncements In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires additional disclosures about significant expenses included in certain expense captions presented on the face of the income statement. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Prospective or retrospective application is allowed and early adoption is permitted. The Company has not determined the impact ASU 2024-03 may have on the Company’s financial statement disclosures. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"), which improves income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The ASU indicates that all entities will apply its guidance prospectively with an option for retrospective application to each period in the financial statements. The Company has not determined the impact ASU 2023-09 may have on the Company’s financial statement disclosures.

Revenues

Revenues	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenues	Revenues The outstanding contract asset and liability accounts were as follows: 2024 2023 (In thousands) Contract assets – January 1 $ 140,826 $ 119,741 Contract assets – December 31 136,432 140,826 Change in contract assets – (decrease) increase (4,394) 21,085 Contract liabilities – January 1 432,830 398,692 Contract liabilities – December 31 400,689 432,830 Change in contract liabilities – decrease (increase) 32,141 (34,138) Net change $ 27,747 $ (13,053) The net change in 2024 and 2023 was primarily driven by lower advance payments from customers on long term contracts. For the years ended December 31, 2024 and 2023, the Company recognized revenue of $359 million and $345 million, respectively, that was previously included in the beginning balance of contract liabilities. Contract assets are reported as a component of Other current assets in the consolidated balance sheet. At December 31, 2024 and 2023, $37.1 million and $57.3 million, respectively, of Customer advanced payments (contract liabilities) were recorded in Other long-term liabilities in the consolidated balance sheet. The remaining performance obligations exceeding one year as of December 31, 2024 and 2023 were $541.8 million and $607.5 million, respectively. Remaining performance obligations represent the transaction price of firm, non-cancelable orders, with expected delivery dates to customers greater than one year from the balance sheet date, for which the performance obligation is unsatisfied or partially unsatisfied. These performance obligations will be substantially satisfied within two Geographic Areas Net sales were attributed to geographic areas based on the location of the customer. Information about the Company’s operations in different geographic areas was as follows for the year ended December 31: 2024 EIG EMG Total (In thousands) United States $ 2,302,951 $ 1,346,483 $ 3,649,434 International (1) : United Kingdom 106,678 126,846 233,524 European Union countries 549,446 427,239 976,685 Asia 1,213,403 218,770 1,432,173 Other foreign countries 487,437 161,927 649,364 Total international 2,356,964 934,782 3,291,746 Consolidated net sales $ 4,659,915 $ 2,281,265 $ 6,941,180 _________________ (1) Includes U.S. export sales of $1,880.8 million. 2023 EIG EMG Total (In thousands) United States $ 2,377,316 $ 1,091,468 $ 3,468,784 International (1) : United Kingdom 99,718 114,770 214,488 European Union countries 518,758 426,219 944,977 Asia 1,175,703 202,425 1,378,128 Other foreign countries 452,755 137,818 590,573 Total international 2,246,934 881,232 3,128,166 Consolidated net sales $ 4,624,250 $ 1,972,700 $ 6,596,950 _________________ (1) Includes U.S. export sales of $1,732.4 million. 2022 EIG EMG Total (In thousands) United States $ 2,171,684 $ 982,579 $ 3,154,263 International (1) : United Kingdom 92,668 117,788 210,456 European Union countries 510,052 420,756 930,808 Asia 1,050,843 266,011 1,316,854 Other foreign countries 404,106 134,043 538,149 Total international 2,057,669 938,598 2,996,267 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 _________________ (1) Includes U.S. export sales of $1,688.7 million Major Products and Services The Company’s major products and services in the reportable segments were as follows for the year ended December 31: 2024 EIG EMG Total (In thousands) Process and analytical instrumentation $ 3,232,918 $ — $ 3,232,918 Aerospace and power 1,426,997 624,570 2,051,567 Automation and engineered solutions — 1,656,695 1,656,695 Consolidated net sales $ 4,659,915 $ 2,281,265 $ 6,941,180 2023 EIG EMG Total (In thousands) Process and analytical instrumentation $ 3,267,698 $ — $ 3,267,698 Aerospace and power 1,356,552 588,446 1,944,998 Automation and engineered solutions — 1,384,254 1,384,254 Consolidated net sales $ 4,624,250 $ 1,972,700 $ 6,596,950 2022 EIG EMG Total (In thousands) Process and analytical instrumentation $ 3,061,263 $ — $ 3,061,263 Aerospace and power 1,168,090 549,735 1,717,825 Automation and engineered solutions — 1,371,442 1,371,442 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 Timing of Revenue Recognition The Company’s timing of revenue recognition was as follows for the year ended December 31: 2024 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,739,209 $ 2,052,862 $ 5,792,071 Products and services transferred over time 920,706 228,403 1,149,109 Consolidated net sales $ 4,659,915 $ 2,281,265 $ 6,941,180 2023 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,831,321 $ 1,772,329 $ 5,603,650 Products and services transferred over time 792,929 200,371 993,300 Consolidated net sales $ 4,624,250 $ 1,972,700 $ 6,596,950 2022 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,471,118 $ 1,680,558 $ 5,151,676 Products and services transferred over time 758,235 240,619 998,854 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 Product Warranties The Company provides limited warranties in connection with the sale of its products. The warranty periods for products sold vary among the Company’s operations, but the majority do not exceed one year. The Company calculates its warranty expense provision based on its historical warranty experience and adjustments are made periodically to reflect actual warranty expenses. Product warranty obligations are reported as a component of Accrued liabilities and other in the consolidated balance sheet. Changes in the accrued product warranty obligation were as follows: 2024 2023 2022 (In thousands) Balance at the beginning of the year $ 37,087 $ 26,487 $ 27,478 Accruals for warranties issued during the year 24,775 23,308 11,414 Settlements made during the year (22,953) (14,219) (11,835) Warranty accruals related to acquired businesses and other during the year (354) 1,511 (570) Balance at the end of the year $ 38,555 $ 37,087 $ 26,487

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company utilizes a hierarchy for disclosure of the inputs to the valuations used to measure fair value. The hierarchy prioritizes the inputs into three broad levels as follows: Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities Level 2 - quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument Level 3 - unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The following tables provide the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31: 2024 Total Level 1 Level 2 Level 3 (In thousands) Mutual fund investments $ 9,124 $ 9,124 $ — $ — Foreign currency forward contracts — — — — 2023 Total Level 1 Level 2 Level 3 (In thousands) Mutual fund investments $ 11,922 $ 11,922 $ — $ — Foreign currency forward contracts 2,035 — 2,035 — The fair value of mutual fund investments is based on quoted market prices. The mutual fund investments are shown as a component of long-term assets in the consolidated balance sheet. For the years ended December 31, 2024 and 2023, gains and losses on the investments were not material. Foreign Currency At December 31, 2024, the Company had no forward contracts outstanding. At December 31, 2023, the Company had a Euro forward contract for a total notional value of 50.0 million Euros. Foreign currency forward contracts are valued as level 2 assets as they are corroborated by foreign currency exchange rates and shown as a component of other current assets in the consolidated balance sheet. For the year ended December 31, 2024 and 2023, realized gains and losses on foreign currency forward contracts were not significant. The Company does not typically designate its foreign currency forward contracts as accounting hedges. Financial Instruments Cash, cash equivalents and mutual fund investments are recorded at fair value at December 31, 2024 and 2023 in the consolidated balance sheet. The fair value of short-term borrowings, net approximates the carrying value. The Company’s long-term debt, net is all privately held with no public market for this debt, therefore, the fair value of long-term debt, net was computed based on comparable current market data for similar debt instruments and is considered to be a level 3 liability. At December 31, 2024 and 2023, the fair value of long-term debt (including current portion) was $1,778.7 million and $2,087.6 million and the recorded amount of long-term debt (including current portion) was $1,851.9 million and $2,197.5 million, respectively. See Note 10 for long-term debt principal amounts, interest rates and maturities.

Hedging Activities

Hedging Activities	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Hedging Activities	Hedging Activities The Company has designated certain foreign-currency-denominated long-term borrowings as hedges of the net investment in certain foreign operations. As of December 31, 2024, and 2023, these net investment hedges included British-pound and Euro-denominated long-term debt. These borrowings were designed to create net investment hedges in each of the designated foreign subsidiaries. The Company designated the British-pound and Euro-denominated loans referred to above as hedging instruments to offset translation gains or losses on the net investment due to changes in the British pound and Euro exchange rates. These net investment hedges are evidenced by management’s contemporaneous documentation supporting the hedge designation. Any gain or loss on the hedging instruments (the debt) following hedge designation is reported in accumulated other comprehensive income in the same manner as the translation adjustment on the hedged investment based on changes in the spot rate, which is used to measure hedge effectiveness. At December 31, 2024 and 2023, the Company had $281.7 million and $286.6 million, respectively, of British-pound denominated loans, and $595.2 million and $580.8 million, respectively, in Euro-denominated loans, which were designated as a hedge against the net investment in Euro and British pound functional currency foreign subsidiaries. As a result of the British-pound and Euro-denominated loans being designated and 100% effective as net investment hedges, $45.6 million of pre-tax currency remeasurement gains and $32.8 million of pre-tax currency remeasurement losses have been included in the foreign currency translation component of other comprehensive income for the years ended December 31, 2024 and 2023, respectively.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	Acquisitions The Company spent $117.5 million in cash, net of cash acquired to acquire Virtek Vision International ("Virtek") in October 2024. Virtek is a leading provider of advanced laser-based projection and inspection systems. Virtek is part of EIG. The following table represents the allocation of the purchase price for the net assets of Virtek based on the estimated fair values at acquisition (in millions): Goodwill $ 70.7 Other intangible assets 60.0 Deferred income taxes (15.9) Net working capital and other (1) 2.7 Total cash paid $ 117.5 ______________________ (1) Includes $6.6 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal. The amount allocated to goodwill is reflective of the benefits the Company expects to realize from the acquisitions. Virtek's advanced 3D laser projectors, smart cameras, and quality control inspection systems complement the Company's existing Creaform business capabilities. At December 31, 2024, the purchase price allocated to other intangible assets of $60.0 million consists of $9.6 million of indefinite-lived intangible trade names, which are not subject to amortization. The remaining $50.4 million of other intangible assets consists of $40.8 million of customer relationships, which are being amortized over a period of 17 years and $9.6 million of purchased technology, which is being amortized over a period of 17 years. Amortization expense for each of the next five years for the acquisitions is expected to be $3.0 million per year. The Virtek acquisition had an immaterial impact on reported net sales, net income, and diluted earnings per share for the year ended December 31, 2024. Had the acquisition been made at the beginning of 2024 or 2023, unaudited pro forma net sales, net income and diluted earnings per share for the year ended December 31, 2024 and 2023, would not have been materially different than the amounts reported. The Company has not finalized its measurements of certain tangible, intangible assets and liabilities and income taxes for the Virtek acquisition. The Company finalized its measurements of certain tangible and intangible assets and liabilities for its August 2023 acquisition of United Electronic Industries and its October 2023 acquisition of Amplifier Research Corp, which had no material impact to the consolidated statement of income and balance sheet. The Company finalized its measurements of certain tangible and intangible assets and liabilities, as well as income tax considerations, for the December 2023 Paragon Medical acquisition. The adjustments include an increase to goodwill of $62.2 million, a decrease to fixed assets of $42.4 million, and a decrease to intangibles of $21.7 million. The final balances for Paragon Medical at December 31, 2024 were $969.2 million of goodwill, $169.0 million of fixed assets, and $852.3 million of intangibles. There was no material impact to the consolidated statement of income. In 2023, the Company spent $2,237.9 million in cash, net of cash acquired, to acquire Paragon Medical ("Paragon") in December 2023, Amplifier Research Corp. ("Amplifier Research") in October 2023, United Electronic Industries ("UEI") in August 2023, and Bison Gear & Engineering Corp. ("Bison") in March 2023. Paragon is a leading provider of highly engineered medical components and instruments. Amplifier Research is a leading manufacturer of radio frequency and microwave amplifiers and electromagnetic compatibility testing equipment. Bison is a leading manufacturer of highly engineered motion control solutions serving diverse markets and applications. UEI is a leading provider of data acquisition and control solutions for the aerospace, defense, energy and semiconductor industries. UEI and Amplifier Research are part of EIG. Paragon and Bison are part of EMG. In 2022, the Company spent $429.7 million in cash, net of cash acquired, to acquire Navitar, Inc.("Navitar") in September 2022 and RTDS Technologies Inc. ("RTDS") in October 2022. Navitar is a market leader in the design, development and manufacturing of customized, fully integrated optical imaging systems, cameras, components and software. RTDS is a leading provider of real-time power simulation systems used by utilities, and research and education institutions in the development and testing of the electric power grid and renewable energy applications. Navitar and RTDS are part of EIG. Acquisition subsequent to December 31, 2024 In January 2025, the Company acquired Kern Microtechnik ("Kern"), a leading manufacturer of high-precision machining and optical inspection solutions supporting a wide range of applications within the medical, semiconductor, research, and space markets. Kern has annual sales of approximately 50 million Euros. Kern will join EIG.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets The changes in the carrying amounts of goodwill by segment were as follows: EIG EMG Total (In millions) Balance at December 31, 2022 $ 4,236.1 $ 1,136.5 $ 5,372.6 Goodwill acquired 79.3 932.4 1,011.7 Purchase price allocation adjustments and other 24.8 — 24.8 Foreign currency translation adjustments 24.8 13.7 38.5 Balance at December 31, 2023 4,365.0 2,082.6 6,447.6 Goodwill acquired 70.7 — 70.7 Purchase price allocation adjustments and other 30.7 61.7 92.4 Foreign currency translation adjustments (41.5) (13.3) (54.8) Balance at December 31, 2024 $ 4,424.9 $ 2,131.0 $ 6,555.9 Other intangible assets were as follows at December 31: 2024 2023 (In thousands) Definite-lived intangible assets (subject to amortization): Patents $ 46,043 $ 47,239 Purchased technology 815,088 914,100 Customer lists 3,823,907 3,743,457 4,685,038 4,704,796 Accumulated amortization: Patents (37,977) (38,105) Purchased technology (378,102) (334,229) Customer lists (1,377,094) (1,190,906) (1,793,173) (1,563,240) Net intangible assets subject to amortization 2,891,865 3,141,556 Indefinite-lived intangible assets (not subject to amortization): Trademarks and trade names 1,023,308 1,023,761 $ 3,915,173 $ 4,165,317 Amortization expense was $247.7 million, $215.1 million, and $205.8 million for the years ended December 31, 2024, 2023 and 2022, respectively. Amortization expense for each of the next five years is expected to approximate $256 million per year, not considering the impact of potential future acquisitions.

Other Consolidated Balance Shee

Other Consolidated Balance Sheet Information	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Other Consolidated Balance Sheet Information	Other Consolidated Balance Sheet Information December 31, 2024 2023 (In thousands) INVENTORIES, NET Finished goods and parts $ 80,491 $ 136,003 Work in process 171,084 165,914 Raw materials and purchased parts 770,138 830,554 $ 1,021,713 $ 1,132,471 PROPERTY, PLANT AND EQUIPMENT, NET Land $ 67,640 $ 67,195 Buildings 449,314 455,015 Machinery and equipment 1,443,288 1,479,702 1,960,242 2,001,912 Less: Accumulated depreciation (1,141,631) (1,110,619) $ 818,611 $ 891,293 ACCRUED LIABILITIES AND OTHER Employee compensation and benefits $ 202,605 $ 228,389 Product warranty obligation 38,555 37,087 Realignment 55,175 41,540 Short term lease liability 54,736 61,055 Other 121,855 134,919 $ 472,926 $ 502,990

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The components of income before income taxes and the details of the provision for income taxes were as follows for the years ended December 31: 2024 2023 2022 (In thousands) Income before income taxes: Domestic $ 991,681 $ 1,026,113 $ 893,478 Foreign 669,858 580,299 535,214 Total $ 1,661,539 $ 1,606,412 $ 1,428,692 Provision for income taxes: Current: Federal $ 120,367 $ 206,477 $ 183,619 Foreign 155,055 144,476 119,148 State 22,936 34,173 34,201 Total current 298,358 385,126 336,968 Deferred: Federal (437) (69,956) (37,810) Foreign (14,317) (15,113) (20,818) State 1,811 (6,833) (9,190) Total deferred (12,943) (91,902) (67,818) Total provision $ 285,415 $ 293,224 $ 269,150 Significant components of the deferred tax (asset) liability were as follows at December 31: 2024 2023 (In thousands) Non-current deferred tax (asset) liability: Differences in basis of property and accelerated depreciation (1) $ 49,513 $ 63,447 Reserves not currently deductible (117,420) (130,761) Pensions 89,508 75,834 Differences in basis of intangible assets and accelerated amortization 849,768 880,666 Net operating loss carryforwards (116,611) (109,065) Share-based compensation (14,614) (14,296) Foreign Tax Credit Carryforwards (2,840) (9,327) Unremitted earnings 13,906 15,033 Other (19,626) (25,893) 731,584 745,638 Less: Valuation allowance 21,305 16,766 752,889 762,404 Portion included in non-current assets 78,141 74,291 Gross non-current deferred tax liability $ 831,030 $ 836,695 ______________________ (1) Presented net of deferred tax assets of approximately $48.8 million and $49.6 million at December 31, 2024 and 2023, respectively, resulting from lease obligations. The Company’s effective tax rate reconciles to the U.S. Federal statutory rate as follows for the years ended December 31: 2024 2023 2022 U.S. Federal statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal income tax benefit 1.4 1.3 1.6 Foreign operations, net 0.5 0.4 (1.0) U.S. Benefits for Manufacturing, Export and credits (3.4) (3.2) (2.9) Uncertain Tax Items (1.9) 1.0 1.0 Stock compensation (0.5) (0.6) (0.9) U.S. Tax / (Benefit) on Foreign Earnings (0.3) (2.0) (0.5) Other 0.4 0.4 0.5 Consolidated effective tax rate 17.2 % 18.3 % 18.8 % The Company elected to pay the cash tax cost of the one-time mandatory tax on previously deferred earnings of non-U.S. subsidiaries over an eight-year period. As of December 31, 2024, the Company has a remaining cash tax obligation of $27.4 million, $15.2 million of w hich is classified as non-current. The Company has evaluated the impact of the global intangible low-taxed income (“GILTI”) section of the Tax Act and has made a tax accounting policy election to record the annual tax cost of GILTI as a current period expense when incurred and, as such, will not be measuring an impact of GILTI in its determination of deferred taxes. As a result of the one-time mandatory deemed repatriation and the taxable inclusions under the GILTI provisions of the Tax Act, the Company has approximately $1.4 billion in previously taxed income (“PTI”) as of December 31, 2024 which can be repatriated without incremental U.S. Federal tax. The Company intends to reinvest its earnings indefinitely in operations outside the United States except to the extent of the PTI. There has been no provision for U.S. deferred income taxes for the undistributed earnings over PTI of approximately $235.8 million and $385.4 million at December 31, 2024 and 2023 respectively because determination of the amount of the unrecognized deferred income tax liability on these undistributed earnings is not practicable. As of December 31, 2024, and 2023, the Company recorded deferred income taxes totaling $13.9 million and $15.0 million respectively in state income and foreign withholding taxes expected to be incurred when the cash amounts related to the previously taxed income are ultimately repatriated to the U.S. The Company is acquisitive and at times acquires entities with tax attributes (net operating losses or tax credits) that carry over to post-acquisition tax periods of the Company. At December 31, 2024, the Company had tax effected benefits, net of uncertain tax positions of $116.6 million related to net operating loss carryforwards, which will be available to offset future income taxes payable, subject to certain annual or other limitations based on foreign and U.S. tax laws. This amount includes net operating loss carryforwards of $0.2 million for federal income tax purposes with no valuation allowance for the U.S. consolidated group, $9.0 million for state income tax purposes with a valuation allowance of $3.0 million, and $107.4 million for foreign income tax purposes with a valuation allowance of $5.6 million. The federal and state net operating loss carryforwards, if not used, will expire between 2025 and 2044. The majority of the foreign net operating loss carryforwards can be carried forward indefinitely with the remaining portion set to expire between 2030 and 2044, if not used. At December 31, 2024, the Company had tax effected benefits of $13.6 million related to tax credit carryforwards, which will be available to offset future income taxes payable, subject to certain annual or other limitations based on foreign and U.S. tax laws. This primarily includes foreign tax credit carryforwards of $2.9 million with no valuation allowance, $9.2 million for state income tax purposes with a valuation allowance of $8.0 million, and $1.5 million for foreign income tax purposes with a valuation allowance of $0.5 million. These tax credit carryforwards, if not used, will expire between 2025 and 2044. As of December 31, 2024, the Company has no remaining carryforwards relating to interest expense limitations under IRC Section 163(j). At December 31, 2023, the Company had $13.2 million of IRC Section 163(j) interest expense limitation carryforwards. The Company maintains a valuation allowance to reduce certain deferred tax assets to amounts that are more likely than not to be realized. This allowance relates to deferred tax assets established for federal, state, and foreign net operating losses, credit carryforwards, and other miscellaneous timing items. In 2024, the Company recorded a net increase of $4.5 million in the valuation allowance. The increase in the valuation allowance primarily relates to $5.3 million recorded against state tax credits which have been deemed more likely than not to go unused. At December 31, 2024, the Company had gross unrecognized tax benefits of $201.6 million, of which $158.2 million, if recognized, would impact the effective tax rate. At December 31, 2023, the Company had gross unrecognized tax benefits of $233.5 million, of which $185.2 million, if recognized, would impact the effective tax rate. At December 31, 2024 and 2023, the Company reported $15.3 million and $18.3 million, respectively, related to interest and penalties as a component of other long term liabilities in the consolidated balance sheet. During 2024, the Company recognized a net benefit of $3.0 million, and in 2023 net expense of $5.9 million, for interest and penalties related to uncertain tax positions in the consolidated statement of income as a component of income tax expense. Approximately 51% of the Company’s overall tax liability is incurred in the United States. The Company files income tax returns in various other state and foreign tax jurisdictions, in some cases for multiple legal entities per jurisdiction. Generally, the Company has open tax years subject to tax audit on average of between three and six years in these jurisdictions. The Company was notified by the Internal Revenue Service ("IRS") that the U.S. consolidated tax group was selected for audit for the 2022 tax year. A preliminary meeting with the IRS and company representatives has been scheduled. The Company has not materially extended any other statutes of limitation for any significant location and has reviewed and accrued for, where necessary, tax liabilities for open periods including state and foreign jurisdictions that remain subject to examination. There have been no penalties asserted or imposed by the IRS related to substantial understatement of income, gross valuation misstatement or failure to disclose a listed or reportable transaction. During 2024, the Company added $65.5 million of tax, interest and penalties related to identified uncertain tax positions and reversed $100.5 million of tax and interest related to statute expirations and settlement of prior uncertain positions. During 2023, the Company added $75.5 million of tax, interest and penalties related to identified uncertain tax positions and reversed $10.7 million of tax and interest related to statute expirations and settlement of prior uncertain positions. The following is a reconciliation of the liability for uncertain tax positions at December 31: 2024 2023 2022 (In millions) Balance at the beginning of the year $ 233.5 $ 174.7 $ 147.0 Additions for tax positions related to the current year 37.2 32.1 29.3 Additions for tax positions of prior years 18.1 34.0 2.1 Reductions for tax positions of prior years (22.8) (0.6) (1.0) Reductions related to settlements with taxing authorities (1.3) (0.1) (0.2) Reductions due to statute expirations (63.1) (6.6) (2.5) Balance at the end of the year $ 201.6 $ 233.5 $ 174.7

Debt

Debt	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt Long-term debt, net consisted of the following at December 31: 2024 2023 (In thousands) U.S. dollar 3.73% senior notes due September 2024 $ — $ 300,000 U.S. dollar 3.91% senior notes due June 2025 50,000 50,000 U.S. dollar 3.96% senior notes due August 2025 100,000 100,000 U.S. dollar 4.18% senior notes due December 2025 275,000 275,000 U.S. dollar 3.83% senior notes due September 2026 100,000 100,000 U.S. dollar 4.32% senior notes due December 2027 250,000 250,000 U.S. dollar 4.37% senior notes due December 2028 50,000 50,000 U.S. dollar 3.98% senior notes due September 2029 100,000 100,000 U.S. dollar 4.45% senior notes due August 2035 50,000 50,000 British pound 2.59% senior note due November 2028 187,803 191,076 British pound 2.70% senior note due November 2031 93,917 95,543 Euro 1.34% senior notes due October 2026 310,514 331,770 Euro 1.71% senior notes due December 2027 77,628 82,945 Euro 1.53% senior notes due October 2028 207,011 221,203 Revolving credit facility borrowings 230,000 1,116,000 Other, principally foreign 1,906 5,534 Less: Debt issuance costs (4,058) (5,724) Total debt, net 2,079,721 3,313,347 Less: Current portion, net (654,346) (1,417,915) Total long-term debt, net $ 1,425,375 $ 1,895,432 Maturities of long-term debt borrowings outstanding at December 31, 2024 were as follows: $410.5 million in 2026; $327.6 million in 2027; $444.8 million in 2028; $100.0 million in 2029; none in 2030; and $142.5 million in 2031 and thereafter. In the third quarter of 2024, the Company paid in full, at maturity, a $300.0 million in aggregate principal amount of 3.73% senior notes. In December 2018, the Company completed a private placement agreement to sell $575 million and 75 million Euros in senior notes to a group of institutional investors (the “2018 Private Placement”) utilizing two funding dates. The first funding occurred in December 2018 for $475 million and 75 million Euros ($77.6 million at December 31, 2024). The second funding was in January 2019 for $100 million. The 2018 Private Placement senior notes carry a weighted average interest rate of 3.93% and are subject to certain customary covenants, including financial covenants that, among other things, require the Company to maintain certain debt-to-EBITDA (earnings before interest, income taxes, depreciation and amortization) and interest coverage ratios. In September 2014, the Company issued $300 million in aggregate principal amount of 3.73% senior notes due September 2024, $100 million in aggregate principal amount of 3.83% senior notes due September 2026 and $100 million in aggregate principal amount of 3.98% senior notes due September 2029. In June 2015, the Company issued $50 million in aggregate principal amount of 3.91% senior notes due June 2025. In August 2015, the Company issued $100 million in aggregate principal amount of 3.96% senior notes due August 2025 and $50 million in aggregate principal amount of 4.45% senior notes due August 2035. In October 2016, the Company issued 300 million Euros ($310.5 million at December 31, 2024) in aggregate principal amount of 1.34% senior notes due October 2026 and 200 million Euros ($207.0 million at December 31, 2024) in aggregate principal amount of 1.53% senior notes due October 2028. In November 2016, the Company issued 150 million British pounds ($187.8 million at December 31, 2024) in aggregate principal amount of 2.59% senior notes due November 2028 and 75 million British pounds ($93.9 million at December 31, 2024) in aggregate principal amount of 2.70% senior notes due November 2031. On May 12, 2022, the Company along with certain of its foreign subsidiaries amended its credit agreement dated as of September 22, 2011, as amended and restated as of March 10, 2016 and as further amended and restated as of October 30, 2018 (the “Credit Agreement”). The Credit Agreement amends and restates the Company’s existing revolving credit facility to increase the size from $1.5 billion to $2.3 billion. The Credit Agreement consists of a five-year revolving credit facility with a final maturity date in May 2027. The revolving credit facility total borrowing capacity excludes an accordion feature that permits the Company to request up to an additional $700 million in revolving credit commitments at any time during the life of the Credit Agreement under certain conditions. The credit agreement places certain restrictions on allowable additional indebtedness. At December 31, 2024, the Company had available borrowing capacity of $2,020.3 million under its revolving credit facility, excluding the $700 million accordion feature. Interest rates on outstanding borrowings under the revolving credit facility are at the applicable benchmark rate plus a negotiated spread or at the U.S. prime rate. At December 31, 2024 and 2023, the Company had $230.0 million and $1,116.0 million of borrowings outstanding under the revolving credit facility, respectively. The weighted average interest rate on the revolving credit facility for the years ended December 31, 2024 and 2023 was 6.31% and 6.22%, respectively. The Company had outstanding letters of credit primarily under the revolving credit facility totaling $49.7 million and $54.7 million at December 31, 2024 and 2023, respectively. The private placements, the senior notes and the revolving credit facility are subject to certain customary covenants, including financial covenants that, among other things, require the Company to maintain certain debt-to-EBITDA and interest coverage ratios. The Company was in compliance with all provisions of the debt arrangements at December 31, 2024. Foreign subsidiaries of the Company had available credit facilities with local foreign lenders of $75.6 million and $73.8 million at December 31, 2024 and 2023, respectively. At December 31, 2024, foreign subsidiaries had $1.9 million in debt borrowings outstanding, which was reported in short-term borrowings. At December 31, 2023, foreign subsidiaries had $5.5 million of debt borrowings outstanding. The weighted average interest rate on total debt borrowings outstanding at December 31, 2024 and 2023 was 3.4% and 4.2%, respectively. Subsequent Event On January 6, 2025, the Company established a commercial paper program under which it may issue short-term, unsecured commercial paper notes. Amounts available under the commercial paper program may be borrowed, repaid and re-borrowed, with the aggregate face or principal amount of the notes outstanding under the commercial paper program at any time not to exceed $2.3 billion. The notes will have maturities of up to 364 days from the date of issue. The Company intends the commercial paper program to provide additional financing flexibility for various purposes including acquisitions. The Company expects that outstanding indebtedness of the Company under both the revolving credit facility and the commercial paper program will not exceed $2.3 billion at any time.

Share-Based Compensation

Share-Based Compensation	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation Under the terms of the Company’s stockholder-approved share-based plans, performance restricted stock units (“PRSUs”), incentive and non-qualified stock options and restricted stock have been, and may be, issued to the Company’s officers, management-level employees and members of its Board of Directors. Stock options granted generally vest at a rate of one-third on each of the first three anniversaries of the grant date and have a maximum contractual term of ten years. Restricted stock granted to employees generally vests one-third on each of the first three anniversaries of the grant date. Restricted stock granted to non-employee directors generally vests two years after the grant date (cliff vesting) and is subject to accelerated vesting due to certain events, including doubling of the grant price of the Company’s common stock as of the close of business during any five consecutive trading days. Share Based Compensation Expense The Company measures and records compensation expense related to all stock awards by recognizing the grant date fair value of the awards over their requisite service periods in the financial statements. For grants under any of the Company’s plans that are subject to graded vesting based on a service condition, the Company recognizes expense on a straight-line basis over the requisite service period for the entire award. Total share-based compensation expense was as follows for the years ended December 31: 2024 2023 2022 (In thousands) Stock option expense $ 13,892 $ 14,284 $ 13,021 Restricted stock expense 20,422 20,792 20,115 PRSU expense 13,549 11,123 14,239 Total pre-tax expense $ 47,863 $ 46,199 $ 47,375 Pre-tax share-based compensation expense is included in the consolidated statement of income in either Cost of sales or Selling, general and administrative expenses, depending on where the recipient’s cash compensation is reported. Stock Options The fair value of each stock option grant is estimated on the date of grant using a Black-Scholes-Merton option pricing model. The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the years indicated: 2024 2023 2022 Expected volatility 28.2 % 26.0 % 24.5 % Expected term (years) 5.0 5.0 5.0 Risk-free interest rate 4.31 % 3.54 % 2.33 % Expected dividend yield 0.62 % 0.72 % 0.65 % Black-Scholes-Merton fair value per stock option granted $ 56.42 $ 38.11 $ 32.54 Expected volatility is based on the historical volatility of the Company’s stock over the stock options’ expected term. The Company used historical exercise data to estimate the stock options’ expected term, which represents the period of time that the stock options granted are expected to be outstanding. Management anticipates that the future stock option holding periods will be similar to the historical stock option holding periods. The risk-free interest rate for periods within the expected term of the stock option is based on the U.S. Treasury yield curve at the time of grant. The expected dividend yield is calculated by dividing the Company’s annual dividend, based on the most recent quarterly dividend rate, by the Company’s closing common stock price on the grant date. Compensation expense recognized for all share-based awards is net of estimated forfeitures. The Company’s estimated forfeiture rates are based on its historical experience. The following is a summary of the Company’s stock option activity and related information for the year ended December 31, 2024: Shares Weighted Weighted Aggregate (In thousands) (Years) (In millions) Outstanding at the beginning of the year 2,741 $ 101.20 Granted 231 181.93 Exercised (779) 85.77 Forfeited (53) 150.00 Outstanding at the end of the year 2,140 $ 114.33 6.5 $ 141.4 Exercisable at the end of the year 1,514 $ 98.55 5.7 $ 123.7 The aggregate intrinsic value of stock options exercised during 2024, 2023 and 2022 was $73.5 million, $54.9 million and $50.3 million, respectively. The total fair value of stock options vested during 2024, 2023 and 2022 was $14.9 million, $12.8 million and $11.4 million, respectively. The following is a summary of the Company’s non-vested stock option activity and related information for the year ended December 31, 2024: Shares Weighted (In thousands) Non-vested stock options outstanding at the beginning of the year 910 $ 34.98 Granted 231 56.42 Vested (462) 32.26 Forfeited (53) 44.68 Non-vested stock options outstanding at the end of the year 626 $ 44.32 As of December 31, 2024, there was approximately $16 million of expected future pre-tax compensation expense related to the 0.6 million non-vested stock options outstanding, which is expected to be recognized over a weighted average period of less than two years. Restricted Stock The fair value of restricted shares under the Company’s restricted stock arrangement is determined by the product of the number of shares granted and the Company’s closing common stock price on the grant date. Upon the grant of restricted stock, the fair value of the restricted shares (unearned compensation) at the grant date is charged as a reduction of capital in excess of par value in the Company’s consolidated balance sheet and is amortized to expense on a straight-line basis over the vesting period, which is the same as the calculated derived service period as determined on the grant date. The following is a summary of the Company’s non-vested restricted stock activity and related information for the year ended December 31, 2024: Shares Weighted (In thousands) Non-vested restricted stock outstanding at the beginning of the year 296 $ 135.39 Granted 149 181.74 Vested (141) 132.82 Forfeited (27) 155.27 Non-vested restricted stock outstanding at the end of the year 277 $ 159.71 The total fair value of restricted stock vested during 2024, 2023 and 2022 was $20.0 million, $20.5 million and $17.7 million, respectively. The weighted average fair value of restricted stock granted per share during 2024 and 2023 was $181.74 and $139.08, respectively. As of December 31, 2024, there was approximately $27 million of expected future pre-tax compensation expense related to the 0.3 million non-vested restricted shares outstanding, which is expected to be recognized over a weighted average period of less than two years. Performance Restricted Stock Units The PRSUs vest over a period up to three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which the Company achieves certain financial and market performance targets measured over the period from January 1 of the year of grant through December 31 of the third year. Half of the PRSUs are valued in a manner similar to restricted stock as the financial targets are based on the Company’s operating results. The grant date fair value of these PRSUs are recognized as compensation expense over the vesting period based on the number of awards expected to vest at each reporting date. The other half of the PRSUs were valued using a Monte Carlo model as the performance target is related to the Company’s total shareholder return compared to a group of peer companies, which represents a market condition. The Company recognizes the grant date fair value of these awards as compensation expense ratably over the vesting period. The following is a summary of the Company’s non-vested performance restricted stock activity and related information for the year ended December 31, 2024: Shares Weighted (In thousands) Non-vested performance restricted stock outstanding at the beginning of the year 239 $ 131.90 Granted 77 167.79 Performance assumption change 1 24 121.91 Vested (99) 121.91 Forfeited (6) 155.83 Non-vested performance restricted stock outstanding at the end of the year 235 $ 150.92 _________________________________________ 1 Reflects the number of PRSUs above target levels based on performance metrics. As of December 31, 2024, there was approximately $5 million of expected future pre-tax compensation expense related to the 0.2 million non-vested performance restricted shares outstanding, which is expected to be recognized over a weighted average period of less than one year. The Company issues previously unissued shares when stock units are exercised, and shares are issued from treasury stock upon the award of restricted stock.

Retirement Plans and Other Post

Retirement Plans and Other Postretirement Benefits	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Retirement Plans and Other Postretirement Benefits	Retirement Plans and Other Postretirement Benefits Retirement and Pension Plans The Company sponsors several retirement and pension plans covering eligible salaried and hourly employees. The plans generally provide benefits based on participants’ years of service and/or compensation. The following is a brief description of the Company’s retirement and pension plans. The Company maintains contributory and non-contributory defined benefit pension plans. Benefits for eligible salaried and hourly employees under all defined benefit plans are funded through trusts established in conjunction with the plans. The Company’s funding policy with respect to its defined benefit plans is to contribute amounts that provide for benefits based on actuarial calculations and the applicable requirements of U.S. federal and local foreign laws. The Company estimates that it will make both required and discretionary cash contributions of approximately $7 million to $10 million to its worldwide defined benefit pension plans in 2025. The Company uses a measurement date of December 31 (its fiscal year end) for its U.S. and foreign defined benefit pension plans. The Company sponsors a 401(k) retirement and savings plan for eligible U.S. employees. Participants in the retirement and savings plan may contribute a specified portion of their compensation on a pre-tax basis, Roth basis, or after-tax basis, which varies by location. The Company matches employee contributions ranging from 33% to 100%, up to a maximum percentage ranging from 1% to 8% of eligible compensation or up to a maximum of $1,200 per participant in some locations. The Company’s retirement and savings plan has a defined contribution retirement feature principally to cover U.S. salaried employees joining the Company after December 31, 1996. Under the retirement feature, the Company makes contributions for eligible employees based on a pre-established percentage of the covered employee’s salary subject to pre-established vesting. Employees of certain of the Company’s foreign operations participate in various local defined contribution plans. The Company has non-qualified unfunded retirement plans for certain Directors and retired employees. It also provides supplemental retirement benefits, through contractual arrangements and/or a Supplemental Executive Retirement Plan (“SERP”) covering certain current and former executives of the Company. These supplemental benefits are designed to compensate the executive for retirement benefits that would have been provided under the Company’s primary retirement plan, except for statutory limitations on compensation that must be taken into account under those plans. The plan permits deferred amounts to be deemed invested in either, or a combination of, an interest-bearing account, phantom mutual fund or collective investment trust accounts or the equivalent of a fund which invests in shares of the Company’s common stock on behalf of the employee. The amount owed to participants is an unfunded and unsecured general obligation which is payable out of either the general assets of the Company or a grant of shares of the Company's common stock upon retirement or termination. The Company is providing for these obligations by charges to earnings over the applicable periods. The following tables set forth the changes in net projected benefit obligation and the fair value of plan assets for the funded and unfunded defined benefit plans for the years ended December 31: U.S. Defined Benefit Pension Plans: 2024 2023 (In thousands) Change in projected benefit obligation: Net projected benefit obligation at the beginning of the year $ 366,248 $ 383,143 Service cost 1,177 1,205 Interest cost 18,998 20,840 Actuarial (gains) losses (10,115) 10,229 Gross benefits paid (30,000) (49,169) Net projected benefit obligation at the end of the year $ 346,308 $ 366,248 Change in plan assets: Fair value of plan assets at the beginning of the year $ 599,886 $ 569,049 Actual return on plan assets 46,900 79,366 Employer contributions 650 640 Gross benefits paid (30,000) (49,169) Fair value of plan assets at the end of the year $ 617,436 $ 599,886 Foreign Defined Benefit Pension Plans: 2024 2023 (In thousands) Change in projected benefit obligation: Net projected benefit obligation at the beginning of the year $ 215,482 $ 198,744 Service cost 1,623 1,615 Interest cost 9,087 9,369 Foreign currency translation adjustments (5,162) 10,312 Actuarial (gains) losses (18,872) 7,575 Expenses paid from assets (579) (552) Gross benefits paid (10,776) (11,581) Net projected benefit obligation at the end of the year $ 190,803 $ 215,482 Change in plan assets: Fair value of plan assets at the beginning of the year $ 174,443 $ 159,592 Actual return on plan assets (2,327) 10,132 Employer contributions 8,044 8,031 Foreign currency translation adjustments (3,038) 8,821 Expenses paid from assets (579) (552) Gross benefits paid (10,776) (11,581) Fair value of plan assets at the end of the year $ 165,767 $ 174,443 The projected benefit obligation assumptions impacting net actuarial losses (gains) primarily consist of changes in discount and mortality rates. The accumulated benefit obligation consisted of the following at December 31: U.S. Defined Benefit Pension Plans: 2024 2023 (In thousands) Funded plans $ 339,029 $ 357,498 Unfunded plans 2,214 2,558 Total $ 341,243 $ 360,056 Foreign Defined Benefit Pension Plans: 2024 2023 (In thousands) Funded plans $ 155,368 $ 178,854 Unfunded plans 35,246 36,360 Total $ 190,614 $ 215,214 Weighted average assumptions used to determine benefit obligations at December 31: 2024 2023 U.S. Defined Benefit Pension Plans: Discount rate 5.74 % 5.38 % Rate of compensation increase (where applicable) 3.75 % 3.75 % Foreign Defined Benefit Pension Plans: Discount rate 5.20 % 4.36 % Rate of compensation increase (where applicable) 3.00 % 3.00 % The following is a summary of the fair value of plan assets for U.S. plans at December 31: 2024 2023 Asset Class Total Level 1 Level 2 Level 3 Total Level 1 Level 2 (In thousands) Corporate debt instruments $ 2,595 $ — $ 2,595 $ — $ 5,295 $ — $ 5,295 Corporate debt instruments – Preferred 18,027 — 18,027 — 16,004 — 16,004 Corporate stocks – Common 56,258 56,258 — — 43,287 43,287 — Municipal bonds 1,456 — 1,456 — 1,253 — 1,253 Hedge Funds 31,900 — — 31,900 — — — Registered investment companies 145,380 145,380 — — 169,794 169,794 — U.S. Government securities 1,141 — 1,141 — 1,262 — 1,262 Total investments 256,757 201,638 23,219 31,900 236,895 213,081 23,814 Investments measured at net asset value 360,679 — — — 362,991 — — Total investments $ 617,436 $ 201,638 $ 23,219 $ 31,900 $ 599,886 $ 213,081 $ 23,814 U.S. equity securities and global equity securities categorized as level 1 are traded on national and international exchanges and are valued at their closing prices on the last trading day of the year. Some U.S. equity securities and global equity securities are public investment vehicles valued using the Net Asset Value (“NAV”) provided by the fund manager. The NAV is the total value of the fund divided by the number of shares outstanding. Fixed income securities categorized as level 2 are valued by the trustee using pricing models that use verifiable observable market data, bids provided by brokers or dealers or quoted prices of securities with similar characteristics. Hedge funds are considered level 3 investments as their values are determined by the sponsor using unobservable market data. The following is a summary of the changes in the fair value of the U.S. plans’ level 3 investments (fair value determined using significant unobservable inputs): Hedge Funds (In thousands) Balance, December 31, 2023 $ — Actual return on assets: Unrealized losses relating to instruments still held at the end of the year — Realized gains (losses) relating to assets sold during the year — Purchases, sales, issuances and settlements, net 31,900 Balance, December 31, 2024 $ 31,900 The expected long-term rate of return on these plan assets was 7.46% in 2024 and 7.59% in 2023. Equity securities included 200,057 shares of AMETEK, Inc. common stock with a market value of $36.1 million (5.8% of total plan investment assets) at December 31, 2024 and 232,710 shares of AMETEK, Inc. common stock with a market value of $38.4 million (6.4% of total plan investment assets) at December 31, 2023. The objectives of the Company’s U.S. defined benefit plans’ investment strategy are to maximize the plans’ funded status and minimize Company contributions and plan expense. Because the goal is to optimize returns over the long term, an investment policy that favors equity holdings has been established. Since there may be periods of time where both equity and mutual fund markets provide poor returns, an allocation to alternative assets may be made to improve the overall portfolio’s diversification and return potential. The Company periodically reviews its asset allocation, taking into consideration plan liabilities, plan benefit payment streams and the investment strategy of the pension plans. The actual asset allocation is monitored frequently relative to the established targets and ranges and is re-balanced when necessary. The target allocations for the U.S. defined benefits plans are approximately 51% equity securities, 29% fixed income securities and 20% other securities and/or cash. The equity portfolio is diversified by market capitalization and style. The equity portfolio also includes international components. The objective of the mutual fund portion of the pension assets is to provide interest rate sensitivity for a portion of the assets and to provide diversification. The mutual fund portfolio is diversified within certain quality and maturity guidelines to minimize the adverse effects of interest rate fluctuations. Certain investments are prohibited and include venture capital, private placements, unregistered or restricted stock, margin trading, commodities, short selling and rights and warrants. Foreign currency futures, options and forward contracts may be used to manage foreign currency exposure. The following is a summary of the fair value of plan assets for foreign defined benefit pension plans at December 31: 2024 2023 Asset Class Total Level 3 Total Level 3 (In thousands) Life insurance $ 10,766 $ 10,766 $ 12,619 $ 12,619 Total investments 10,766 10,766 12,619 12,619 Investments measured at net asset value 155,001 — 161,824 — Total investments $ 165,767 $ 10,766 $ 174,443 $ 12,619 Life insurance assets are considered level 3 investments as their values are determined by the sponsor using unobservable market data. Life insurance assets categorized as level 3 are valued based on unobservable inputs and cannot be corroborated using verifiable observable market data. Investments in level 3 funds are redeemable, however, cash reimbursement may be delayed, or a portion held back until asset finalization. The following is a summary of the changes in the fair value of the foreign plans’ level 3 investments (fair value determined using significant unobservable inputs): Life Insurance (In thousands) Balance, December 31, 2022 $ 13,043 Actual return on assets: Unrealized losses relating to instruments still held at the end of the year $ (424) Realized gains (losses) relating to assets sold during the year $ — Purchases, sales, issuances and settlements, net $ — Balance, December 31, 2023 $ 12,619 Actual return on assets: Unrealized losses relating to instruments still held at the end of the year $ (1,853) Realized gains (losses) relating to assets sold during the year $ — Purchases, sales, issuances and settlements, net $ — Balance, December 31, 2024 $ 10,766 The objective of the Company’s foreign defined benefit plans’ investment strategy is to maximize the long-term rate of return on plan investments, subject to a reasonable level of risk. Liability studies are also performed on a regular basis to provide guidance in setting investment goals with an objective to balance risks against the current and future needs of the plans. The trustees consider the risk associated with the different asset classes, relative to the plans’ liabilities and how this can be affected by diversification, and the relative returns available on equities, mutual fund investments, real estate and cash. Also, the likely volatility of those returns and the cash flow requirements of the plans are considered. It is expected that equities will outperform mutual fund investments over the long term. However, the trustees recognize the fact that mutual fund investments may better match the liabilities for pensioners. Because of the relatively young active employee group covered by the plans and the immature nature of the plans, the trustees have chosen to adopt an asset allocation strategy more heavily weighted toward equity investments. This asset allocation strategy will be reviewed, from time to time, in view of changes in market conditions and in the plans’ liability profile. The target allocations for the foreign defined benefit plans are approximately 23% equity securities, 70% fixed income securities and 7% other securities, insurance or cash. The assumption for the expected return on plan assets was developed based on a review of historical investment returns for the investment categories for the defined benefit pension assets. This review also considered current capital market conditions and projected future investment returns. The estimates of future capital market returns by asset class are lower than the actual long-term historical returns. Therefore, the assumed rate of return for U.S. plans is 7.13% and 5.78% for foreign plans in 2025. The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with a projected benefit obligation in excess of plan assets and pension plans with an accumulated benefit obligation in excess of plan assets were as follows at December 31: U.S. Defined Benefit Pension Plans: Projected Benefit Accumulated Benefit 2024 2023 2024 2023 (In thousands) Benefit obligation $ 2,214 $ 2,558 $ 2,214 $ 2,558 Fair value of plan assets — — — — Foreign Defined Benefit Pension Plans: Projected Benefit Accumulated Benefit 2024 2023 2024 2023 (In thousands) Benefit obligation $ 35,435 $ 132,796 $ 35,246 $ 132,527 Fair value of plan assets 2,316 88,028 2,316 88,028 The following table provides the amounts recognized in the consolidated balance sheet at December 31: 2024 2023 (In thousands) Funded status asset (liability): Fair value of plan assets $ 783,203 $ 774,329 Projected benefit obligation (537,111) (581,730) Funded status at the end of the year $ 246,092 $ 192,599 Amounts recognized in the consolidated balance sheet consisted of: Non-current asset for pension benefits (other assets) $ 281,425 $ 239,925 Current liabilities for pension benefits (2,294) (2,816) Non-current liability for pension benefits (33,039) (44,510) Net amount recognized at the end of the year $ 246,092 $ 192,599 The following table provides the amounts recognized in accumulated other comprehensive income, net of taxes, at December 31: Net amounts recognized: 2024 2023 (In thousands) Net actuarial loss $ 162,086 $ 184,489 Prior service costs 1,519 1,616 Transition asset 1 2 Total recognized $ 163,606 $ 186,107 The following table provides the components of net periodic pension benefit expense (income) for the years ended December 31: 2024 2023 2022 (In thousands) Defined benefit plans: Service cost $ 2,800 $ 2,820 $ 4,919 Interest cost 28,085 30,209 20,124 Expected return on plan assets (54,672) (52,289) (60,104) Settlement — — (58) Amortization of: Net actuarial loss 9,619 11,569 8,531 Prior service costs 103 101 100 Transition asset 1 1 1 Total net periodic benefit income (14,064) (7,589) (26,487) Other plans: Defined contribution plans 44,898 43,044 39,326 Foreign plans and other 8,575 9,015 8,373 Total other plans 53,473 52,059 47,699 Total net pension expense $ 39,409 $ 44,470 $ 21,212 The total net periodic benefit expense (income) is included in Cost of sales, General and administrative expense and Other income and expense The following weighted average assumptions were used to determine the above net periodic pension benefit income for the years ended December 31: 2024 2023 2022 U.S. Defined Benefit Pension Plans: Discount rate 5.38 % 5.65 % 3.02 % Expected return on plan assets 7.46 % 7.59 % 6.75 % Rate of compensation increase (where applicable) 3.75 % 3.75 % 3.75 % Foreign Defined Benefit Pension Plans: Discount rate 4.36 % 4.73 % 1.78 % Expected return on plan assets 6.49 % 6.41 % 5.85 % Rate of compensation increase (where applicable) 3.00 % 2.50 % 2.50 % Estimated Future Benefit Payments The estimated future benefit payments for U.S. and foreign plans are as follows: 2025 – $42.9 million; 2026 – $43.2 million; 2027 – $43.0 million; 2028 – $43.2 million; 2029 – $42.8 million; 2030 to 2034 - $208.1 million. Future benefit payments primarily represent amounts to be paid from pension trust assets. Amounts included that are to be paid from the Company’s assets are not significant in any individual year. Postretirement Plans and Post-employment Benefits The Company provides limited postretirement benefits other than pensions for certain retirees and a small number of former employees. Benefits under these arrangements are not funded and are not significant. The Company also provides limited post-employment benefits for certain former or inactive employees after employment but before retirement. Those benefits are not significant in amount. The Company has a deferred compensation plan, which allows employees whose compensation exceeds the statutory IRS limit for retirement benefits to defer a portion of earned bonus compensation. The plan permits deferred amounts to be deemed invested in either, or a combination of, an interest-bearing account, phantom mutual fund accounts or the equivalent of a fund which invests in shares of the Company’s common stock on behalf of the employee. The amount owed to participants is an unfunded and unsecured general obligation which is payable out of either the general assets of the Company or a grant of shares of the Company's common stock. The amount deferred under the plan, including income earned, was $44.5 million and $35.9 million at December 31, 2024 and 2023, respectively. Administrative expense for the deferred compensation plan is borne by the Company and is not significant.

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Indemnifications In conjunction with certain acquisition and divestiture transactions, the Company may agree to make payments to compensate or indemnify other parties for possible future unfavorable financial consequences resulting from specified events (e.g., breaches of contract obligations or retention of previously existing environmental, tax or employee liabilities) whose terms range in duration and often are not explicitly defined. Where appropriate, the obligation for such indemnifications is recorded as a liability. Because the amount of these types of indemnifications generally is not specifically stated, the overall maximum amount of the obligation under such indemnifications cannot be reasonably estimated. Further, the Company indemnifies its directors and officers for claims against them in connection with their positions with the Company. Historically, any such costs incurred to settle claims related to these indemnifications have been minimal for the Company. The Company believes that future payments, if any, under all existing indemnification agreements would not have a material impact on its consolidated results of operations, financial position or cash flows. Asbestos Litigation The Company (including its subsidiaries) has been named as a defendant in a number of asbestos-related lawsuits. Certain of these lawsuits relate to a business which was acquired by the Company and do not involve products which were manufactured or sold by the Company. In connection with these lawsuits, the seller of such business has agreed to indemnify the Company against these claims (the “Indemnified Claims”). The Indemnified Claims have been tendered to, and are being defended by, such seller. The seller has met its obligations, in all respects, and the Company does not have any reason to believe such party would fail to fulfill its obligations in the future. To date, no judgments have been rendered against the Company as a result of any asbestos-related lawsuit. The Company believes that it has good and valid defenses to each of these claims and intends to defend them vigorously. Environmental Matters Certain historic processes in the manufacture of products have resulted in environmentally hazardous waste by-products as defined by federal and state laws and regulations. At December 31, 2024, the Company is named a Potentially Responsible Party (“PRP”) at 13 non-AMETEK-owned former waste disposal or treatment sites (the “non-owned”sites). The Company is identified as a “de minimis” party in a majority of these sites based on the low volume of waste attributed to the Company relative to the amounts attributed to other named PRPs. The Company is participating in the investigation and/or related required remediation as part of a PRP Group and reserves have been established sufficient to satisfy the Company’s expected obligations. The Company historically has resolved these issues within established reserve levels and reasonably expects this result will continue. In addition to these non-owned sites, the Company has an ongoing practice of providing reserves for probable remediation activities at certain of its current or previously owned manufacturing locations (the “owned” sites). For claims and proceedings against the Company with respect to other environmental matters, reserves are established once the Company has determined that a loss is probable and estimable. This estimate is refined as the Company moves through the various stages of investigation, risk assessment, feasibility study and corrective action processes. In certain instances, the Company has developed a range of estimates for such costs and has recorded a liability based on the best estimate. It is reasonably possible that the actual cost of remediation of the individual sites could vary from the current estimates and the amounts accrued in the consolidated financial statements; however, the amounts of such variances are not expected to result in a material change to the consolidated financial statements. In estimating the Company’s liability for remediation, the Company also considers the likely proportionate share of the anticipated remediation expense and the ability of the other PRPs to fulfill their obligations. Total environmental reserves at December 31, 2024 and 2023 were $29.8 million and $37.1 million, respectively, for both non-owned and owned sites. In 2024, the Company recorded $9.7 million in reserves. Additionally, in 2024 the Company spent $17.0 million on environmental matters. The total environmental expense is included in Other income and expense in the consolidated statement of income. The Company has agreements with other former owners of certain of its acquired businesses, as well as new owners of previously owned businesses. Under certain of the agreements, the former or new owners retained, or assumed and agreed to indemnify the Company against, certain environmental and other liabilities under certain circumstances. The Company and some of these other parties also carry insurance coverage for some environmental matters.

Leases and Other Commitments

Leases and Other Commitments	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Leases and Other Commitments	Leases and Other Commitments Leases The Company has commitments under operating leases for certain facilities, vehicles and equipment used in its operations. Cash used in operations for operating leases was not materially different from operating lease expense for the years ended December 31, 2024 and 2023. Our leases have initial lease terms ranging from 1 month to 15 years. The components of lease expense were as follows: 2024 2023 2022 (In thousands) Operating lease cost $ 76,315 $ 63,049 $ 59,296 Variable lease cost 11,730 11,384 11,096 Total lease cost $ 88,045 $ 74,433 $ 70,392 Supplemental balance sheet information related to leases was as follows: December 31, 2024 2023 (In thousands) Right of use assets, net $ 235,666 $ 229,723 Lease liabilities included in Accrued liabilities and other 54,736 61,055 Lease liabilities included in Other long-term liabilities 190,017 182,436 Total lease liabilities $ 244,753 $ 243,491 Supplemental cash flow information and other information related to leases was as follows for the year ended December 31: 2024 2023 (In thousands) Right-of-use assets obtained in exchange for new operating liabilities $ 44,079 $ 95,052 Weighted-average remaining lease terms – operating leases (years) 6.49 6.66 Weighted-average discount rate – operating leases 4.74 % 4.48 % Maturities of lease liabilities as of December 31, 2024 were as follows: Lease Liability Maturity Analysis Operating Leases (In thousands) 2025 $ 61,789 2026 52,241 2027 39,654 2028 29,419 2029 23,576 Thereafter 71,426 Total lease payments 278,105 Less: imputed interest 33,352 $ 244,753 The Company does not have any significant leases that have not yet commenced. Other Commitments As of December 31, 2024, and 2023, the Company had $761.9 million and $790.0 million, respectively, in purchase obligations outstanding, which primarily consisted of contractual commitments to purchase certain inventories at fixed prices.

Reportable Segments and Geograp

Reportable Segments and Geographic Areas Information	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Reportable Segments and Geographic Areas Information	Reportable Segments and Geographic Areas Information Descriptive Information about Reportable Segments The Company has two reportable segments, EIG and EMG. The Company’s operating segments are determined based on information utilized by the Chief Executive Officer, its chief operating decision maker ("CODM"). Certain of the Company’s operating segments have been aggregated for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and similarity of economic characteristics. EIG manufactures advanced instruments for the process, power and industrial, and aerospace markets. It provides process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries. EIG also provides instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets. It makes power quality monitoring and metering devices, uninterruptible power supplies, programmable power equipment, electromagnetic compatibility test equipment and gas turbines sensors. EIG also provides dashboard instruments for heavy trucks and other vehicles, as well as instrumentation and controls for the food and beverage industries. It supplies the aerospace and defense industry with aircraft and engine sensors, embedded computing systems, monitoring systems, power supplies, fuel and fluid measurement systems, and data acquisition systems. EMG designs and manufactures highly engineered medical components and devices, automation solutions, thermal management systems, specialty metals and electrical interconnects. EMG products include single-use and consumable surgical instruments, implantable components, and drug delivery systems used across a wide range of medical applications. It also manufactures highly engineered electrical connectors and electronic packaging used to protect sensitive electronic devices. EMG makes precision motion control products for data storage, medical devices, business equipment, automation and other applications. It supplies high-purity powdered metals, strip and foil, specialty clad metals and metal matrix composites. EMG also manufactures motors used in commercial appliances, food and beverage machines, hydraulic pumps and industrial blowers. It produces motor-blower systems and heat exchangers used in thermal management and other applications on a variety of military and commercial aircraft and military ground vehicles. EMG also operates a global network of aviation maintenance, repair and overhaul facilities. Measurement of Segment Results The CODM reviews segment operating income statements in order to assess performance and allocate resources to each segment. Sales and operating income are key metrics monitored by the CODM when determining each segment’s financial condition and operating performance. In addition, the CODM receives depreciation, amortization, research, development, and engineering costs, capital spending, and assets of each segment on a quarterly basis to monitor cash flow and asset needs of each segment. Segment operating income represents net sales less all direct costs and expenses (including certain administrative and other expenses) applicable to each segment but does not include interest expense. Net sales by segment are reported after elimination of intra- and inter-segment sales and profits, which are insignificant in amount. Reported segment assets include allocations directly related to the segment’s operations. Corporate assets consist primarily of investments, pensions, insurance deposits and deferred taxes. Reportable Segment Financial Information (in thousands): EMG EIG Corporate Total Consolidated 2024 Net Sales $ 2,281,265 $ 4,659,915 $ — $ 6,941,180 Cost of sales (1) 1,736,694 2,728,019 — 4,464,713 Selling expense 88,070 503,487 — 591,557 Segment Operating Income 456,501 1,428,409 — 1,884,910 Corporate G&A — — 105,348 105,348 Operating Income 456,501 1,428,409 (105,348) 1,779,562 Interest expense — — (112,962) (112,962) Other (expense) income, net — — (5,061) (5,061) Income before Income Taxes $ 456,501 $ 1,428,409 $ (223,371) $ 1,661,539 Depreciation $ 58,049 $ 71,351 $ 5,866 $ 135,266 Amortization 74,452 173,209 — 247,661 Total depreciation and amortization $ 132,501 $ 244,560 $ 5,866 $ 382,927 Research, Development & Engineering costs (2) $ 72,434 $ 299,441 $ — $ 371,875 Assets $ 4,758,856 $ 9,302,031 $ 570,282 $ 14,631,169 Capital Expenditures (3) $ 41,022 $ 58,859 $ 28,277 $ 128,158 (1) Includes $29.2 million in EMG in for Paragon integration costs. (2) Included in cost of sales. (3) Includes $1.1 million in EIG from acquired businesses. EMG EIG Corporate Total Consolidated 2023 Net Sales $ 1,972,700 $ 4,624,250 $ — $ 6,596,950 Cost of sales 1,393,086 2,819,399 — 4,212,485 Selling expense 83,045 493,889 — 576,934 Segment Operating Income 496,569 1,310,962 — 1,807,531 Corporate G&A — — 100,072 100,072 Operating Income 496,569 1,310,962 (100,072) 1,707,459 Interest expense — — (81,795) (81,795) Other (expense) income, net — — (19,252) (19,252) Income before Income Taxes $ 496,569 $ 1,310,962 $ (201,119) $ 1,606,412 Depreciation $ 40,443 $ 77,344 $ 4,715 $ 122,502 Amortization 43,471 171,663 — 215,134 Total depreciation and amortization $ 83,914 $ 249,007 $ 4,715 $ 337,636 Research, Development & Engineering costs (1) $ 68,960 $ 282,701 $ — $ 351,661 Assets $ 4,957,944 $ 9,559,282 $ 506,307 $ 15,023,533 Capital Expenditures (2) $ 272,060 $ 86,616 $ 12,385 $ 371,061 (1) Included in cost of sales. (2) Includes $223.7 million in EMG, and $11.1 million in EIG from acquired businesses. EMG EIG Corporate Total Consolidated 2022 Net Sales $ 1,921,177 $ 4,229,353 $ — $ 6,150,530 Cost of sales (1) 1,337,108 2,668,153 — 4,005,261 Selling expense 80,476 471,471 — 551,947 Segment Operating Income 503,593 1,089,729 — 1,593,322 Corporate G&A — — 92,630 92,630 Operating Income 503,593 1,089,729 (92,630) 1,500,692 Interest expense — — (83,186) (83,186) Other income (expense), net — — 11,186 11,186 Income before Income Taxes $ 503,593 $ 1,089,729 $ (164,630) $ 1,428,692 Depreciation $ 37,474 $ 73,093 $ 3,095 $ 113,662 Amortization 40,422 165,343 — 205,765 Total depreciation and amortization $ 77,896 $ 238,436 $ 3,095 $ 319,427 Research, Development & Engineering costs (2) $ 63,892 $ 258,178 $ — $ 322,070 Assets $ 2,617,685 $ 9,430,797 $ 382,638 $ 12,431,120 Capital Expenditures (3) $ 38,186 $ 93,505 $ 19,757 $ 151,448 (1) Includes $7.1 million in EMG from a gain on the sale of a facility. (2) Included in cost of sales. (3) Includes $12.3 million in EIG and $0.1 million in Corporate from acquired businesses. Geographic Areas Information about the Company’s operations in different geographic areas for the years ended December 31, 2024 and 2023 is shown below. 2024 2023 (In thousands) Long-lived assets from continuing operations (excluding intangible assets): United States $ 590,386 $ 646,381 International (1) : United Kingdom 68,239 73,328 European Union countries 84,707 95,781 Asia 12,416 13,351 Other foreign countries 62,863 62,452 Total international 228,225 244,912 Total consolidated $ 818,611 $ 891,293 _________________ (1) Represents long-lived assets of foreign-based operations only.

Additional Consolidated Income

Additional Consolidated Income Statement and Cash Flow Information	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Additional Consolidated Income Statement and Cash Flow Information	Additional Consolidated Income Statement and Cash Flow Information Included in other income (expense), net are interest and other investment income of $6.8 million, $12.0 million and $1.0 million for 2024, 2023 and 2022, respectively. Income taxes paid in 2024, 2023 and 2022 were $302.2 million, $336.2 million and $299.3 million, respectively. Cash paid for interest was $113.9 million, $66.3 million and $80.2 million in 2024, 2023 and 2022, respectively.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity In 2023, the Company repurchased approximately 0.1 million shares of its common stock for $7.8 million in cash under its share repurchase authorization. On May 5, 2022, the Company's Board of Directors approved a $1 billion authorization of its common stock, which replaced the previous $500 million authorization announced in February 2019. In 2024, the Company repurchased approximately 1.3 million shares of its common stock for $223.1 million in cash under its share repurchase authorization. At December 31, 2024, $593.1 million was available under the Company’s Board of Directors authorization for future share repurchases. Effective February 9, 2024, the Company’s Board of Directors approved a 12% increase in the quarterly cash dividend on the Company’s common stock to $0.28 per common share from $0.25 per common share. At December 31, 2024, the Company held 39.4 million shares in its treasury at a cost of $2,114.0 million, compared with 38.4 million shares at a cost of $1,896.6 million at December 31, 2023. The number of shares outstanding at December 31, 2024 was 230.7 million shares, compared with 230.9 million shares at December 31, 2023. Subsequent Events Effective February 7, 2025, the Company's Board of Directors approved an 11% increase in the quarterly cash dividend on its common stock to $0.31 per share from $0.28 per share.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net income	$ 1,376,124	$ 1,313,188	$ 1,159,542

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	AMETEK’s cybersecurity risk management practices are based on the widely recognized National Institute of Standards and Technology Framework for Improving Critical Infrastructure Cybersecurity (The NIST Cybersecurity Framework and the NIST 800-171 Revision 2 Standard). This guidance was developed with private sector input and provides a framework and toolkit for organizations to manage cybersecurity risk. We utilize a broad team of in-house information technology and security personnel, as well as third-party consultants, services and software, to help manage our cybersecurity efforts and initiatives. We regularly assess our threat landscape and monitor our systems and other technical security controls. Additionally, we maintain information security policies and procedures, including a breach response plan and maintenance of backup and protective systems. We regularly review our policies, practices, and plans with assistance from third-party experts and advisors. Our Chief Information Officer is responsible for corporate-wide data security. Our management team is actively engaged in regular reviews of cyber risks. Additionally, our full Board of Directors receives quarterly briefings on enterprise-wide cybersecurity risk management and our overall cybersecurity risk environment. We have implemented two risk management groups, the Enterprise Risk Management Committee, and the Cybersecurity Steering Committee. These committees meet quarterly. They are responsible for the overall governance of our cyber management. The implementation of the Cyber polices and strategy is the responsibility of the Chief Information Officer and the Director of Cyber Security. The CIO reports to the Chief Administrative Officer and the Director of Cyber Security reports to the CIO. We also have a team of full-time cybersecurity specialists who hold various industry technology accreditations. The CIO has more than 35 years in Senior IT Leadership positions, and the Director of Cyber Security has more than 30 years IT experience overall, 15 of which are in leadership roles. Operationally, we deploy multiple layers of cyber defenses including multiple tools and processes that identify security risks across our global networks, largely in real time. We also maintain good relationships with law enforcement agencies to remain informed on potential cyber risks. Mandatory cybersecurity training is conducted eight times a year for all of AMETEK’s employees with email access. The training provides critical information on how employees can protect themselves and AMETEK against cybersecurity risks. AMETEK financial professionals receive additional training due to the nature of their roles.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	We utilize a broad team of in-house information technology and security personnel, as well as third-party consultants, services and software, to help manage our cybersecurity efforts and initiatives. We regularly assess our threat landscape and monitor our systems and other technical security controls. Additionally, we maintain information security policies and procedures, including a breach response plan and maintenance of backup and protective systems.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	We regularly review our policies, practices, and plans with assistance from third-party experts and advisors. Our Chief Information Officer is responsible for corporate-wide data security. Our management team is actively engaged in regular reviews of cyber risks. Additionally, our full Board of Directors receives quarterly briefings on enterprise-wide cybersecurity risk management and our overall cybersecurity risk environment.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	We regularly review our policies, practices, and plans with assistance from third-party experts and advisors. Our Chief Information Officer is responsible for corporate-wide data security. Our management team is actively engaged in regular reviews of cyber risks. Additionally, our full Board of Directors receives quarterly briefings on enterprise-wide cybersecurity risk management and our overall cybersecurity risk environment
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	We regularly review our policies, practices, and plans with assistance from third-party experts and advisors. Our Chief Information Officer is responsible for corporate-wide data security. Our management team is actively engaged in regular reviews of cyber risks. Additionally, our full Board of Directors receives quarterly briefings on enterprise-wide cybersecurity risk management and our overall cybersecurity risk environment
Cybersecurity Risk Role of Management [Text Block]	Operationally, we deploy multiple layers of cyber defenses including multiple tools and processes that identify security risks across our global networks, largely in real time. We also maintain good relationships with law enforcement agencies to remain informed on potential cyber risks.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	We have implemented two risk management groups, the Enterprise Risk Management Committee, and the Cybersecurity Steering Committee. These committees meet quarterly. They are responsible for the overall governance of our cyber management.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	We also have a team of full-time cybersecurity specialists who hold various industry technology accreditations. The CIO has more than 35 years in Senior IT Leadership positions, and the Director of Cyber Security has more than 30 years IT experience overall, 15 of which are in leadership roles.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	We regularly review our policies, practices, and plans with assistance from third-party experts and advisors. Our Chief Information Officer is responsible for corporate-wide data security. Our management team is actively engaged in regular reviews of cyber risks. Additionally, our full Board of Directors receives quarterly briefings on enterprise-wide cybersecurity risk management and our overall cybersecurity risk environment.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Basis of Consolidation	Basis of Consolidation
Use of Estimates	Use of Estimates
Cash Equivalents, Securities and Other Investments	Cash Equivalents, Securities and Other Investments
Accounts Receivable	Accounts Receivable
Inventories	Inventories The Company predominantly uses the first-in, first-out (“FIFO”) method of inventory accounting, which approximates current replacement cost, at December 31, 2024. The last-in, first-out (“LIFO”) method of accounting is used to determine cost for 10% of the Company’s inventory at December 31, 2024. For inventories where cost is determined by the LIFO method, the FIFO value would have been $40.8 million and $39.0 million higher than the LIFO value reported in the consolidated balance sheet at December 31, 2024 and 2023, respectively. The Company provides estimated inventory reserves for slow-moving and obsolete inventory based on current assessments about future demand, market conditions, customers who may be experiencing financial difficulties and related management initiatives.
Business Combinations	Business Combinations The Company allocates the purchase price of an acquired company, including when applicable, the acquisition date fair value of contingent consideration between tangible and intangible assets acquired and liabilities assumed from the acquired business based on their estimated fair values, with the residual of the purchase price
Property, Plant and Equipment	Property, Plant and Equipment
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill and other intangible assets with indefinite lives, primarily trademarks and trade names, are not amortized; rather, they are tested for impairment at least annually. The Company identifies its reporting units at the component level, which is one level below its operating segments. Generally, goodwill arises from acquisitions of specific operating companies and is assigned to the reporting unit in which the operating company resides. The Company’s reporting units are divisions that are one level below its operating segments and for which discrete financial information is prepared and regularly reviewed by segment management. The Company principally relies on a discounted cash flow analysis to determine the fair value of each reporting unit, which considers cash flows discounted at an appropriate discount rate. The Company believes that market participants would use a discounted cash flow analysis to determine the fair value of its reporting units in a sale transaction. The annual goodwill impairment test requires the Company to make a number of assumptions and estimates concerning future levels of revenue growth, operating margins, depreciation, amortization and working capital requirements, which are based on the Company’s long-range plan and are considered level 3 inputs. The Company's long-range plan is updated as part of its annual planning process and is reviewed and approved by management. The discount rate is an estimate of the overall after-tax rate of return required by a market participant whose weighted average cost of capital includes both equity and debt, including a risk premium. The impairment test for indefinite-lived intangibles other than goodwill (primarily trademarks and trade names) consists of a comparison of the estimated fair value of the indefinite-lived intangible asset to the carrying value of the asset as of the impairment testing date. The Company estimates the fair value of its indefinite-lived intangibles using the relief from royalty method using level 3 inputs for revenue growth rates and royalty rates. The fair value derived from the relief from royalty method is measured as the discounted cash flow savings realized from owning such trademarks and trade names and not having to pay a royalty for their use. The Company completed its required annual impairment tests as of October 1, 2024, 2023, and 2022 and determined that the carrying values of the Company's goodwill were not impaired. The Company completed its required annual indefinite-lived intangibles impairment test as of October 1, 2024 and determined that the carrying values of the Company's trademarks and trade names with indefinite lives were not impaired. The Company completed its required annual impairment test in the fourth quarter of 2023 and 2022 and determined that the carrying values of certain of the Company's trademarks and trade names with indefinite lives were impaired and as a result, during the fourth quarter of 2023 and 2022, the Company recorded an immaterial non-cash impairment charge related to certain of the Company's trade names. Other intangible assets with finite lives are evaluated for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of other intangible assets with finite lives is considered impaired when the total projected undiscounted cash flows from the asset group are less than the carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of those assets. Fair value is determined primarily using present value techniques based on projected cash flows from the asset group. nine ten
Financial Instruments and Foreign Currency Translation	Financial Instruments and Foreign Currency Translation Assets and liabilities of foreign operations are translated using exchange rates in effect at the balance sheet date and their results of operations are translated using average exchange rates for the year. Certain transactions of the Company and its subsidiaries are denominated in currencies other than their functional currency. Exchange gains and losses from those transactions are included in operating results for the year. The Company makes infrequent use of derivative financial instruments. Forward contracts are primarily entered into from time to time to hedge debt or foreign currency transactions, thereby minimizing the Company’s exposure to foreign currency fluctuation.
Leases	Leases The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. The Company has lease agreements which include lease and non-lease components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable. Operating leases are included in right-of-use ("ROU") assets, accrued liabilities and other, and other long-term liabilities on our consolidated balance sheets. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company primarily leases buildings (real estate) and automobiles which are classified as operating leases. The lease term for all of the Company’s leases includes the non-cancellable period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company’s leases as the reasonably certain threshold is not met. Lease payments included in the measurement of the lease liability are comprised of fixed and variable payments that depend on an index or rate.
Revenue Recognition	Revenue Recognition Revenue is derived from sales of products and services. The Company’s products and services are marketed and sold worldwide through two operating groups: EIG and EMG. See Note 15 Descriptive Information about Reportable Segments. The majority of the Company’s revenues on product sales were recognized at a point in time when the customer obtains control of the product. The transfer in control of the product to the customer was typically evidenced by one or more of the following: the customer having legal title to the product, the Company’s present right to payment, the customer’s physical possession of the product, the customer accepting the product, or the customer having the benefits of ownership or risk of loss. For a small percentage of sales where title and risk of loss transfers at the point of delivery, the Company recognized revenue upon delivery to the customer, which is the point that control transferred, assuming all other criteria for revenue recognition were met. The Company determined that revenues from certain of its customer contracts met the criteria of satisfying its performance obligations over time, primarily in the areas of the manufacture of custom-made equipment and for service repairs of customer-owned equipment. Recognizing revenue over time for custom-manufactured equipment is based on the Company’s judgment that, in certain contracts, the product does not have an alternative use and the Company has an enforceable right to payment for performance completed to date. The Company recognizes incremental cost of obtaining contracts as an expense when incurred if the amortization period of the contract cost assets that the Company would have otherwise recognized is one year or less. These costs are included in Selling, general and administrative expenses in the consolidated statement of income. The determination of the revenue to be recognized in each period for performance obligations satisfied over time is based on the input method. The Company recognizes revenue over time as it performs on these contracts because the transfer of control to the customer occurs over time. Revenue is recognized based on the extent of progress towards completion of the performance obligation. The Company generally uses the total cost-to-cost input method of progress because it best depicts the transfer of control to the customer that occurs as costs are incurred. Under the cost-to-cost method, the extent of progress towards completion is measured based on the proportion of costs incurred to date to the total estimated costs at completion of the performance obligation. On certain contracts, labor hours are used as the measure of progress when it is determined to be a better depiction of the transfer of control to the customer due to the timing and pattern of labor hours incurred. Performance obligations also include post-delivery service, installation and training. Post-delivery service revenues are recognized over the contract term. Installation and training revenues are recognized over the period the service is provided. Warranty terms in customer contracts can also be considered separate performance obligations if the warranty provides services beyond assurance that a product complies with agreed-upon specification or if a warranty can be purchased separately. The Company does not incur significant obligations for customer returns and refunds. The Company has certain contracts with variable consideration in the form of volume discounts, rebates and early payment options, which may affect the transaction price used as the basis for revenue recognition. Payment terms generally begin upon shipment of the product. The Company does have contracts with multiple billing terms that are all due within one year from when the product is delivered. No significant financing component exists. Payment terms are generally 30-60 days from the time of shipment or customer acceptance, but terms can be shorter or longer, not exceeding one year. For customer contracts that have revenue recognized over time, revenue is generally recognized prior to a payment being due from the customer. In such cases, the Company recognizes a contract asset at the time the revenue is recognized. When payment becomes due based on the contract terms, the Company reduces the contract asset and records a receivable. In contracts with billing milestones or in other instances with a long production cycle or concerns about credit, customer advance payments are received. The
Research and Development	Research and Development Research and development costs are included in Cost of sales as incurred and were $236.6 million in 2024, $220.8 million in 2023 and $198.8 million in 2022.
Shipping and Handling Costs	Shipping and Handling Costs
Share-Based Compensation	Share-Based Compensation
Income Taxes	Income Taxes The Company conducts a broad range of operations around the world and is therefore subject to complex tax regulations in numerous international taxing jurisdictions, resulting at times in tax audits, disputes and potential litigation, the outcome of which is uncertain. Management must make judgments currently about such uncertainties and determine estimates of the Company’s tax assets and liabilities. To the extent the final outcome differs, future adjustments to the Company’s tax assets and liabilities may be necessary. The Company assesses the realizability of its deferred tax assets, taking into consideration the Company’s forecast of future taxable income, available net operating loss carryforwards and available tax planning strategies that could be implemented to realize the deferred tax assets. Based on this assessment, management must evaluate the need for, and amount of, valuation allowances against the Company’s deferred tax assets. The Company assesses the uncertainty in its tax positions, by applying a minimum recognition threshold which a tax position is required to meet before a tax benefit is recognized in the financial statements. Once the minimum threshold is met, using a more likely than not standard, a series of probability estimates is made for each item to properly measure and record a tax benefit. The tax benefit recorded is generally equal to the highest probable outcome that is more than 50% likely to be realized after full disclosure and resolution of a tax examination. The underlying probabilities are determined based on the best available objective evidence such as recent tax audit outcomes, published guidance, external expert opinion, or by analogy to the outcome of similar issues in the past. There can be no assurance that these estimates will ultimately be realized given continuous changes in tax policy, legislation and audit practice. The Company recognizes interest and penalties accrued related to uncertain tax positions in income tax expense.
Pensions	Pensions
Earnings Per Share	Earnings Per Share
Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncement	Recently Adopted Accounting Pronouncement In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which requires disclosure of significant segment expenses and other segment items on an annual and interim basis under ASC 280. The Company retrospectively adopted ASU 2023-07, effective December 31, 2024, and the adoption resulted in additional disclosures in the Reportable Segments footnote. Recent Accounting Pronouncements In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires additional disclosures about significant expenses included in certain expense captions presented on the face of the income statement. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Prospective or retrospective application is allowed and early adoption is permitted. The Company has not determined the impact ASU 2024-03 may have on the Company’s financial statement disclosures. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"), which improves income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The ASU indicates that all entities will apply its guidance prospectively with an option for retrospective application to each period in the financial statements. The Company has not determined the impact ASU 2023-09 may have on the Company’s financial statement disclosures.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Summary Of Allowance for Credit Loss	The following table provides a roll forward of the allowance for estimated credit losses: 2024 2023 (in thousands) Balance at January 1 $ 13,167 $ 14,102 Bad debt expense 2,546 3,984 Amounts written off charged against allowance (2,506) (4,908) Foreign currency translation and other (175) (11) Balance at December 31 $ 13,032 $ 13,167
Number of Weighted Average Shares	The number of weighted average shares used in the calculation of basic earnings per share and diluted earnings per share was as follows for the years ended December 31: 2024 2023 2022 (In thousands) Weighted average shares: Basic shares 231,256 230,519 230,208 Equity-based compensation plans 912 990 1,328 Diluted shares 232,168 231,509 231,536

Revenues (Tables)

Revenues (Tables)	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Outstanding Contract Asset and (Liability) Accounts	The outstanding contract asset and liability accounts were as follows: 2024 2023 (In thousands) Contract assets – January 1 $ 140,826 $ 119,741 Contract assets – December 31 136,432 140,826 Change in contract assets – (decrease) increase (4,394) 21,085 Contract liabilities – January 1 432,830 398,692 Contract liabilities – December 31 400,689 432,830 Change in contract liabilities – decrease (increase) 32,141 (34,138) Net change $ 27,747 $ (13,053)
Revenue from External Customers by Geographic Areas	Information about the Company’s operations in different geographic areas was as follows for the year ended December 31: 2024 EIG EMG Total (In thousands) United States $ 2,302,951 $ 1,346,483 $ 3,649,434 International (1) : United Kingdom 106,678 126,846 233,524 European Union countries 549,446 427,239 976,685 Asia 1,213,403 218,770 1,432,173 Other foreign countries 487,437 161,927 649,364 Total international 2,356,964 934,782 3,291,746 Consolidated net sales $ 4,659,915 $ 2,281,265 $ 6,941,180 _________________ (1) Includes U.S. export sales of $1,880.8 million. 2023 EIG EMG Total (In thousands) United States $ 2,377,316 $ 1,091,468 $ 3,468,784 International (1) : United Kingdom 99,718 114,770 214,488 European Union countries 518,758 426,219 944,977 Asia 1,175,703 202,425 1,378,128 Other foreign countries 452,755 137,818 590,573 Total international 2,246,934 881,232 3,128,166 Consolidated net sales $ 4,624,250 $ 1,972,700 $ 6,596,950 _________________ (1) Includes U.S. export sales of $1,732.4 million. 2022 EIG EMG Total (In thousands) United States $ 2,171,684 $ 982,579 $ 3,154,263 International (1) : United Kingdom 92,668 117,788 210,456 European Union countries 510,052 420,756 930,808 Asia 1,050,843 266,011 1,316,854 Other foreign countries 404,106 134,043 538,149 Total international 2,057,669 938,598 2,996,267 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530 _________________ (1)
Revenue from External Customers by Products and Services	The Company’s major products and services in the reportable segments were as follows for the year ended December 31: 2024 EIG EMG Total (In thousands) Process and analytical instrumentation $ 3,232,918 $ — $ 3,232,918 Aerospace and power 1,426,997 624,570 2,051,567 Automation and engineered solutions — 1,656,695 1,656,695 Consolidated net sales $ 4,659,915 $ 2,281,265 $ 6,941,180 2023 EIG EMG Total (In thousands) Process and analytical instrumentation $ 3,267,698 $ — $ 3,267,698 Aerospace and power 1,356,552 588,446 1,944,998 Automation and engineered solutions — 1,384,254 1,384,254 Consolidated net sales $ 4,624,250 $ 1,972,700 $ 6,596,950 2022 EIG EMG Total (In thousands) Process and analytical instrumentation $ 3,061,263 $ — $ 3,061,263 Aerospace and power 1,168,090 549,735 1,717,825 Automation and engineered solutions — 1,371,442 1,371,442 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530
Schedule of Disaggregation of Revenue	The Company’s timing of revenue recognition was as follows for the year ended December 31: 2024 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,739,209 $ 2,052,862 $ 5,792,071 Products and services transferred over time 920,706 228,403 1,149,109 Consolidated net sales $ 4,659,915 $ 2,281,265 $ 6,941,180 2023 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,831,321 $ 1,772,329 $ 5,603,650 Products and services transferred over time 792,929 200,371 993,300 Consolidated net sales $ 4,624,250 $ 1,972,700 $ 6,596,950 2022 EIG EMG Total (In thousands) Products transferred at a point in time $ 3,471,118 $ 1,680,558 $ 5,151,676 Products and services transferred over time 758,235 240,619 998,854 Consolidated net sales $ 4,229,353 $ 1,921,177 $ 6,150,530
Schedule of Product Warranty Liability	Changes in the accrued product warranty obligation were as follows: 2024 2023 2022 (In thousands) Balance at the beginning of the year $ 37,087 $ 26,487 $ 27,478 Accruals for warranties issued during the year 24,775 23,308 11,414 Settlements made during the year (22,953) (14,219) (11,835) Warranty accruals related to acquired businesses and other during the year (354) 1,511 (570) Balance at the end of the year $ 38,555 $ 37,087 $ 26,487

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value of Assets Measured on Recurring Basis	The following tables provide the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31: 2024 Total Level 1 Level 2 Level 3 (In thousands) Mutual fund investments $ 9,124 $ 9,124 $ — $ — Foreign currency forward contracts — — — — 2023 Total Level 1 Level 2 Level 3 (In thousands) Mutual fund investments $ 11,922 $ 11,922 $ — $ — Foreign currency forward contracts 2,035 — 2,035 —

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Allocation of Aggregate Purchase Price of Acquired Net Assets	The following table represents the allocation of the purchase price for the net assets of Virtek based on the estimated fair values at acquisition (in millions): Goodwill $ 70.7 Other intangible assets 60.0 Deferred income taxes (15.9) Net working capital and other (1) 2.7 Total cash paid $ 117.5 ______________________ (1) Includes $6.6 million in accounts receivable, whose fair value, contractual cash flows and expected cash flows are approximately equal.

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Carrying Amounts of Goodwill by Segment	The changes in the carrying amounts of goodwill by segment were as follows: EIG EMG Total (In millions) Balance at December 31, 2022 $ 4,236.1 $ 1,136.5 $ 5,372.6 Goodwill acquired 79.3 932.4 1,011.7 Purchase price allocation adjustments and other 24.8 — 24.8 Foreign currency translation adjustments 24.8 13.7 38.5 Balance at December 31, 2023 4,365.0 2,082.6 6,447.6 Goodwill acquired 70.7 — 70.7 Purchase price allocation adjustments and other 30.7 61.7 92.4 Foreign currency translation adjustments (41.5) (13.3) (54.8) Balance at December 31, 2024 $ 4,424.9 $ 2,131.0 $ 6,555.9
Other Intangible Assets	Other intangible assets were as follows at December 31: 2024 2023 (In thousands) Definite-lived intangible assets (subject to amortization): Patents $ 46,043 $ 47,239 Purchased technology 815,088 914,100 Customer lists 3,823,907 3,743,457 4,685,038 4,704,796 Accumulated amortization: Patents (37,977) (38,105) Purchased technology (378,102) (334,229) Customer lists (1,377,094) (1,190,906) (1,793,173) (1,563,240) Net intangible assets subject to amortization 2,891,865 3,141,556 Indefinite-lived intangible assets (not subject to amortization): Trademarks and trade names 1,023,308 1,023,761 $ 3,915,173 $ 4,165,317

Other Consolidated Balance Sh_2

Other Consolidated Balance Sheet Information (Tables)	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Other Consolidated Balance Sheet Information	December 31, 2024 2023 (In thousands) INVENTORIES, NET Finished goods and parts $ 80,491 $ 136,003 Work in process 171,084 165,914 Raw materials and purchased parts 770,138 830,554 $ 1,021,713 $ 1,132,471 PROPERTY, PLANT AND EQUIPMENT, NET Land $ 67,640 $ 67,195 Buildings 449,314 455,015 Machinery and equipment 1,443,288 1,479,702 1,960,242 2,001,912 Less: Accumulated depreciation (1,141,631) (1,110,619) $ 818,611 $ 891,293 ACCRUED LIABILITIES AND OTHER Employee compensation and benefits $ 202,605 $ 228,389 Product warranty obligation 38,555 37,087 Realignment 55,175 41,540 Short term lease liability 54,736 61,055 Other 121,855 134,919 $ 472,926 $ 502,990

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Components of Income before Income Taxes and Details of Provision for Income Taxes	The components of income before income taxes and the details of the provision for income taxes were as follows for the years ended December 31: 2024 2023 2022 (In thousands) Income before income taxes: Domestic $ 991,681 $ 1,026,113 $ 893,478 Foreign 669,858 580,299 535,214 Total $ 1,661,539 $ 1,606,412 $ 1,428,692 Provision for income taxes: Current: Federal $ 120,367 $ 206,477 $ 183,619 Foreign 155,055 144,476 119,148 State 22,936 34,173 34,201 Total current 298,358 385,126 336,968 Deferred: Federal (437) (69,956) (37,810) Foreign (14,317) (15,113) (20,818) State 1,811 (6,833) (9,190) Total deferred (12,943) (91,902) (67,818) Total provision $ 285,415 $ 293,224 $ 269,150
Components of Deferred Tax (Asset) Liability	Significant components of the deferred tax (asset) liability were as follows at December 31: 2024 2023 (In thousands) Non-current deferred tax (asset) liability: Differences in basis of property and accelerated depreciation (1) $ 49,513 $ 63,447 Reserves not currently deductible (117,420) (130,761) Pensions 89,508 75,834 Differences in basis of intangible assets and accelerated amortization 849,768 880,666 Net operating loss carryforwards (116,611) (109,065) Share-based compensation (14,614) (14,296) Foreign Tax Credit Carryforwards (2,840) (9,327) Unremitted earnings 13,906 15,033 Other (19,626) (25,893) 731,584 745,638 Less: Valuation allowance 21,305 16,766 752,889 762,404 Portion included in non-current assets 78,141 74,291 Gross non-current deferred tax liability $ 831,030 $ 836,695 ______________________ (1) Presented net of deferred tax assets of approximately $48.8 million and $49.6 million at December 31, 2024 and 2023, respectively, resulting from lease obligations.
Reconciliation of Effective Tax Rate to U.S. Federal Statutory Rate	The Company’s effective tax rate reconciles to the U.S. Federal statutory rate as follows for the years ended December 31: 2024 2023 2022 U.S. Federal statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal income tax benefit 1.4 1.3 1.6 Foreign operations, net 0.5 0.4 (1.0) U.S. Benefits for Manufacturing, Export and credits (3.4) (3.2) (2.9) Uncertain Tax Items (1.9) 1.0 1.0 Stock compensation (0.5) (0.6) (0.9) U.S. Tax / (Benefit) on Foreign Earnings (0.3) (2.0) (0.5) Other 0.4 0.4 0.5 Consolidated effective tax rate 17.2 % 18.3 % 18.8 %
Reconciliation of Liability for Uncertain Tax Positions	The following is a reconciliation of the liability for uncertain tax positions at December 31: 2024 2023 2022 (In millions) Balance at the beginning of the year $ 233.5 $ 174.7 $ 147.0 Additions for tax positions related to the current year 37.2 32.1 29.3 Additions for tax positions of prior years 18.1 34.0 2.1 Reductions for tax positions of prior years (22.8) (0.6) (1.0) Reductions related to settlements with taxing authorities (1.3) (0.1) (0.2) Reductions due to statute expirations (63.1) (6.6) (2.5) Balance at the end of the year $ 201.6 $ 233.5 $ 174.7

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Long-term Debt	Long-term debt, net consisted of the following at December 31: 2024 2023 (In thousands) U.S. dollar 3.73% senior notes due September 2024 $ — $ 300,000 U.S. dollar 3.91% senior notes due June 2025 50,000 50,000 U.S. dollar 3.96% senior notes due August 2025 100,000 100,000 U.S. dollar 4.18% senior notes due December 2025 275,000 275,000 U.S. dollar 3.83% senior notes due September 2026 100,000 100,000 U.S. dollar 4.32% senior notes due December 2027 250,000 250,000 U.S. dollar 4.37% senior notes due December 2028 50,000 50,000 U.S. dollar 3.98% senior notes due September 2029 100,000 100,000 U.S. dollar 4.45% senior notes due August 2035 50,000 50,000 British pound 2.59% senior note due November 2028 187,803 191,076 British pound 2.70% senior note due November 2031 93,917 95,543 Euro 1.34% senior notes due October 2026 310,514 331,770 Euro 1.71% senior notes due December 2027 77,628 82,945 Euro 1.53% senior notes due October 2028 207,011 221,203 Revolving credit facility borrowings 230,000 1,116,000 Other, principally foreign 1,906 5,534 Less: Debt issuance costs (4,058) (5,724) Total debt, net 2,079,721 3,313,347 Less: Current portion, net (654,346) (1,417,915) Total long-term debt, net $ 1,425,375 $ 1,895,432

Share-Based Compensation (Table

Share-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Total Share-Based Compensation Expense	Total share-based compensation expense was as follows for the years ended December 31: 2024 2023 2022 (In thousands) Stock option expense $ 13,892 $ 14,284 $ 13,021 Restricted stock expense 20,422 20,792 20,115 PRSU expense 13,549 11,123 14,239 Total pre-tax expense $ 47,863 $ 46,199 $ 47,375
Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted	The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the years indicated: 2024 2023 2022 Expected volatility 28.2 % 26.0 % 24.5 % Expected term (years) 5.0 5.0 5.0 Risk-free interest rate 4.31 % 3.54 % 2.33 % Expected dividend yield 0.62 % 0.72 % 0.65 % Black-Scholes-Merton fair value per stock option granted $ 56.42 $ 38.11 $ 32.54
Summary of Stock Option Activity and Related Information	The following is a summary of the Company’s stock option activity and related information for the year ended December 31, 2024: Shares Weighted Weighted Aggregate (In thousands) (Years) (In millions) Outstanding at the beginning of the year 2,741 $ 101.20 Granted 231 181.93 Exercised (779) 85.77 Forfeited (53) 150.00 Outstanding at the end of the year 2,140 $ 114.33 6.5 $ 141.4 Exercisable at the end of the year 1,514 $ 98.55 5.7 $ 123.7
Summary of Nonvested Stock Option Activity and Related Information	The following is a summary of the Company’s non-vested stock option activity and related information for the year ended December 31, 2024: Shares Weighted (In thousands) Non-vested stock options outstanding at the beginning of the year 910 $ 34.98 Granted 231 56.42 Vested (462) 32.26 Forfeited (53) 44.68 Non-vested stock options outstanding at the end of the year 626 $ 44.32
Summary of Nonvested Restricted Stock Activity and Related Information	The following is a summary of the Company’s non-vested restricted stock activity and related information for the year ended December 31, 2024: Shares Weighted (In thousands) Non-vested restricted stock outstanding at the beginning of the year 296 $ 135.39 Granted 149 181.74 Vested (141) 132.82 Forfeited (27) 155.27 Non-vested restricted stock outstanding at the end of the year 277 $ 159.71 The following is a summary of the Company’s non-vested performance restricted stock activity and related information for the year ended December 31, 2024: Shares Weighted (In thousands) Non-vested performance restricted stock outstanding at the beginning of the year 239 $ 131.90 Granted 77 167.79 Performance assumption change 1 24 121.91 Vested (99) 121.91 Forfeited (6) 155.83 Non-vested performance restricted stock outstanding at the end of the year 235 $ 150.92 _________________________________________ 1 Reflects the number of PRSUs above target levels based on performance metrics.

Retirement Plans and Other Po_2

Retirement Plans and Other Postretirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Net Projected Benefit Obligation and Fair Value of Plan Assets for Funded and Unfunded Defined Benefit Plans	The following tables set forth the changes in net projected benefit obligation and the fair value of plan assets for the funded and unfunded defined benefit plans for the years ended December 31: U.S. Defined Benefit Pension Plans: 2024 2023 (In thousands) Change in projected benefit obligation: Net projected benefit obligation at the beginning of the year $ 366,248 $ 383,143 Service cost 1,177 1,205 Interest cost 18,998 20,840 Actuarial (gains) losses (10,115) 10,229 Gross benefits paid (30,000) (49,169) Net projected benefit obligation at the end of the year $ 346,308 $ 366,248 Change in plan assets: Fair value of plan assets at the beginning of the year $ 599,886 $ 569,049 Actual return on plan assets 46,900 79,366 Employer contributions 650 640 Gross benefits paid (30,000) (49,169) Fair value of plan assets at the end of the year $ 617,436 $ 599,886 Foreign Defined Benefit Pension Plans: 2024 2023 (In thousands) Change in projected benefit obligation: Net projected benefit obligation at the beginning of the year $ 215,482 $ 198,744 Service cost 1,623 1,615 Interest cost 9,087 9,369 Foreign currency translation adjustments (5,162) 10,312 Actuarial (gains) losses (18,872) 7,575 Expenses paid from assets (579) (552) Gross benefits paid (10,776) (11,581) Net projected benefit obligation at the end of the year $ 190,803 $ 215,482 Change in plan assets: Fair value of plan assets at the beginning of the year $ 174,443 $ 159,592 Actual return on plan assets (2,327) 10,132 Employer contributions 8,044 8,031 Foreign currency translation adjustments (3,038) 8,821 Expenses paid from assets (579) (552) Gross benefits paid (10,776) (11,581) Fair value of plan assets at the end of the year $ 165,767 $ 174,443
Accumulated Benefit Obligation ("ABO")	The accumulated benefit obligation consisted of the following at December 31: U.S. Defined Benefit Pension Plans: 2024 2023 (In thousands) Funded plans $ 339,029 $ 357,498 Unfunded plans 2,214 2,558 Total $ 341,243 $ 360,056 Foreign Defined Benefit Pension Plans: 2024 2023 (In thousands) Funded plans $ 155,368 $ 178,854 Unfunded plans 35,246 36,360 Total $ 190,614 $ 215,214
Weighted Average Assumptions Used to Determine Benefit Obligations	Weighted average assumptions used to determine benefit obligations at December 31: 2024 2023 U.S. Defined Benefit Pension Plans: Discount rate 5.74 % 5.38 % Rate of compensation increase (where applicable) 3.75 % 3.75 % Foreign Defined Benefit Pension Plans: Discount rate 5.20 % 4.36 % Rate of compensation increase (where applicable) 3.00 % 3.00 % The following weighted average assumptions were used to determine the above net periodic pension benefit income for the years ended December 31: 2024 2023 2022 U.S. Defined Benefit Pension Plans: Discount rate 5.38 % 5.65 % 3.02 % Expected return on plan assets 7.46 % 7.59 % 6.75 % Rate of compensation increase (where applicable) 3.75 % 3.75 % 3.75 % Foreign Defined Benefit Pension Plans: Discount rate 4.36 % 4.73 % 1.78 % Expected return on plan assets 6.49 % 6.41 % 5.85 % Rate of compensation increase (where applicable) 3.00 % 2.50 % 2.50 %
Fair Value of Plan Assets	The following is a summary of the fair value of plan assets for U.S. plans at December 31: 2024 2023 Asset Class Total Level 1 Level 2 Level 3 Total Level 1 Level 2 (In thousands) Corporate debt instruments $ 2,595 $ — $ 2,595 $ — $ 5,295 $ — $ 5,295 Corporate debt instruments – Preferred 18,027 — 18,027 — 16,004 — 16,004 Corporate stocks – Common 56,258 56,258 — — 43,287 43,287 — Municipal bonds 1,456 — 1,456 — 1,253 — 1,253 Hedge Funds 31,900 — — 31,900 — — — Registered investment companies 145,380 145,380 — — 169,794 169,794 — U.S. Government securities 1,141 — 1,141 — 1,262 — 1,262 Total investments 256,757 201,638 23,219 31,900 236,895 213,081 23,814 Investments measured at net asset value 360,679 — — — 362,991 — — Total investments $ 617,436 $ 201,638 $ 23,219 $ 31,900 $ 599,886 $ 213,081 $ 23,814 The following is a summary of the fair value of plan assets for foreign defined benefit pension plans at December 31: 2024 2023 Asset Class Total Level 3 Total Level 3 (In thousands) Life insurance $ 10,766 $ 10,766 $ 12,619 $ 12,619 Total investments 10,766 10,766 12,619 12,619 Investments measured at net asset value 155,001 — 161,824 — Total investments $ 165,767 $ 10,766 $ 174,443 $ 12,619
Summary of Changes in Fair Value of U.S. Plans' Investments Using Significant Unobservable Inputs	The following is a summary of the changes in the fair value of the U.S. plans’ level 3 investments (fair value determined using significant unobservable inputs): Hedge Funds (In thousands) Balance, December 31, 2023 $ — Actual return on assets: Unrealized losses relating to instruments still held at the end of the year — Realized gains (losses) relating to assets sold during the year — Purchases, sales, issuances and settlements, net 31,900 Balance, December 31, 2024 $ 31,900 The following is a summary of the changes in the fair value of the foreign plans’ level 3 investments (fair value determined using significant unobservable inputs): Life Insurance (In thousands) Balance, December 31, 2022 $ 13,043 Actual return on assets: Unrealized losses relating to instruments still held at the end of the year $ (424) Realized gains (losses) relating to assets sold during the year $ — Purchases, sales, issuances and settlements, net $ — Balance, December 31, 2023 $ 12,619 Actual return on assets: Unrealized losses relating to instruments still held at the end of the year $ (1,853) Realized gains (losses) relating to assets sold during the year $ — Purchases, sales, issuances and settlements, net $ — Balance, December 31, 2024 $ 10,766
Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets	The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with a projected benefit obligation in excess of plan assets and pension plans with an accumulated benefit obligation in excess of plan assets were as follows at December 31: U.S. Defined Benefit Pension Plans: Projected Benefit Accumulated Benefit 2024 2023 2024 2023 (In thousands) Benefit obligation $ 2,214 $ 2,558 $ 2,214 $ 2,558 Fair value of plan assets — — — — Foreign Defined Benefit Pension Plans: Projected Benefit Accumulated Benefit 2024 2023 2024 2023 (In thousands) Benefit obligation $ 35,435 $ 132,796 $ 35,246 $ 132,527 Fair value of plan assets 2,316 88,028 2,316 88,028
Funded Status of Plan and Amounts Recognized in Balance Sheet	The following table provides the amounts recognized in the consolidated balance sheet at December 31: 2024 2023 (In thousands) Funded status asset (liability): Fair value of plan assets $ 783,203 $ 774,329 Projected benefit obligation (537,111) (581,730) Funded status at the end of the year $ 246,092 $ 192,599 Amounts recognized in the consolidated balance sheet consisted of: Non-current asset for pension benefits (other assets) $ 281,425 $ 239,925 Current liabilities for pension benefits (2,294) (2,816) Non-current liability for pension benefits (33,039) (44,510) Net amount recognized at the end of the year $ 246,092 $ 192,599
Amounts Recognized in Accumulated Other Comprehensive Income, Net of Taxes	The following table provides the amounts recognized in accumulated other comprehensive income, net of taxes, at December 31: Net amounts recognized: 2024 2023 (In thousands) Net actuarial loss $ 162,086 $ 184,489 Prior service costs 1,519 1,616 Transition asset 1 2 Total recognized $ 163,606 $ 186,107
Components of Net Periodic Pension Benefit Expense (Income)	The following table provides the components of net periodic pension benefit expense (income) for the years ended December 31: 2024 2023 2022 (In thousands) Defined benefit plans: Service cost $ 2,800 $ 2,820 $ 4,919 Interest cost 28,085 30,209 20,124 Expected return on plan assets (54,672) (52,289) (60,104) Settlement — — (58) Amortization of: Net actuarial loss 9,619 11,569 8,531 Prior service costs 103 101 100 Transition asset 1 1 1 Total net periodic benefit income (14,064) (7,589) (26,487) Other plans: Defined contribution plans 44,898 43,044 39,326 Foreign plans and other 8,575 9,015 8,373 Total other plans 53,473 52,059 47,699 Total net pension expense $ 39,409 $ 44,470 $ 21,212

Leases and Other Commitments (T

Leases and Other Commitments (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Components of Lease Expense	The components of lease expense were as follows: 2024 2023 2022 (In thousands) Operating lease cost $ 76,315 $ 63,049 $ 59,296 Variable lease cost 11,730 11,384 11,096 Total lease cost $ 88,045 $ 74,433 $ 70,392
Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to leases was as follows: December 31, 2024 2023 (In thousands) Right of use assets, net $ 235,666 $ 229,723 Lease liabilities included in Accrued liabilities and other 54,736 61,055 Lease liabilities included in Other long-term liabilities 190,017 182,436 Total lease liabilities $ 244,753 $ 243,491
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information and other information related to leases was as follows for the year ended December 31: 2024 2023 (In thousands) Right-of-use assets obtained in exchange for new operating liabilities $ 44,079 $ 95,052 Weighted-average remaining lease terms – operating leases (years) 6.49 6.66 Weighted-average discount rate – operating leases 4.74 % 4.48 %
Maturities of Lease Liabilities	Maturities of lease liabilities as of December 31, 2024 were as follows: Lease Liability Maturity Analysis Operating Leases (In thousands) 2025 $ 61,789 2026 52,241 2027 39,654 2028 29,419 2029 23,576 Thereafter 71,426 Total lease payments 278,105 Less: imputed interest 33,352 $ 244,753

Reportable Segments and Geogr_2

Reportable Segments and Geographic Areas Information (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Reportable Segment Financial Information	Reportable Segment Financial Information (in thousands): EMG EIG Corporate Total Consolidated 2024 Net Sales $ 2,281,265 $ 4,659,915 $ — $ 6,941,180 Cost of sales (1) 1,736,694 2,728,019 — 4,464,713 Selling expense 88,070 503,487 — 591,557 Segment Operating Income 456,501 1,428,409 — 1,884,910 Corporate G&A — — 105,348 105,348 Operating Income 456,501 1,428,409 (105,348) 1,779,562 Interest expense — — (112,962) (112,962) Other (expense) income, net — — (5,061) (5,061) Income before Income Taxes $ 456,501 $ 1,428,409 $ (223,371) $ 1,661,539 Depreciation $ 58,049 $ 71,351 $ 5,866 $ 135,266 Amortization 74,452 173,209 — 247,661 Total depreciation and amortization $ 132,501 $ 244,560 $ 5,866 $ 382,927 Research, Development & Engineering costs (2) $ 72,434 $ 299,441 $ — $ 371,875 Assets $ 4,758,856 $ 9,302,031 $ 570,282 $ 14,631,169 Capital Expenditures (3) $ 41,022 $ 58,859 $ 28,277 $ 128,158 (1) Includes $29.2 million in EMG in for Paragon integration costs. (2) Included in cost of sales. (3) Includes $1.1 million in EIG from acquired businesses. EMG EIG Corporate Total Consolidated 2023 Net Sales $ 1,972,700 $ 4,624,250 $ — $ 6,596,950 Cost of sales 1,393,086 2,819,399 — 4,212,485 Selling expense 83,045 493,889 — 576,934 Segment Operating Income 496,569 1,310,962 — 1,807,531 Corporate G&A — — 100,072 100,072 Operating Income 496,569 1,310,962 (100,072) 1,707,459 Interest expense — — (81,795) (81,795) Other (expense) income, net — — (19,252) (19,252) Income before Income Taxes $ 496,569 $ 1,310,962 $ (201,119) $ 1,606,412 Depreciation $ 40,443 $ 77,344 $ 4,715 $ 122,502 Amortization 43,471 171,663 — 215,134 Total depreciation and amortization $ 83,914 $ 249,007 $ 4,715 $ 337,636 Research, Development & Engineering costs (1) $ 68,960 $ 282,701 $ — $ 351,661 Assets $ 4,957,944 $ 9,559,282 $ 506,307 $ 15,023,533 Capital Expenditures (2) $ 272,060 $ 86,616 $ 12,385 $ 371,061 (1) Included in cost of sales. (2) Includes $223.7 million in EMG, and $11.1 million in EIG from acquired businesses. EMG EIG Corporate Total Consolidated 2022 Net Sales $ 1,921,177 $ 4,229,353 $ — $ 6,150,530 Cost of sales (1) 1,337,108 2,668,153 — 4,005,261 Selling expense 80,476 471,471 — 551,947 Segment Operating Income 503,593 1,089,729 — 1,593,322 Corporate G&A — — 92,630 92,630 Operating Income 503,593 1,089,729 (92,630) 1,500,692 Interest expense — — (83,186) (83,186) Other income (expense), net — — 11,186 11,186 Income before Income Taxes $ 503,593 $ 1,089,729 $ (164,630) $ 1,428,692 Depreciation $ 37,474 $ 73,093 $ 3,095 $ 113,662 Amortization 40,422 165,343 — 205,765 Total depreciation and amortization $ 77,896 $ 238,436 $ 3,095 $ 319,427 Research, Development & Engineering costs (2) $ 63,892 $ 258,178 $ — $ 322,070 Assets $ 2,617,685 $ 9,430,797 $ 382,638 $ 12,431,120 Capital Expenditures (3) $ 38,186 $ 93,505 $ 19,757 $ 151,448 (1) Includes $7.1 million in EMG from a gain on the sale of a facility. (2) Included in cost of sales. (3) Includes $12.3 million in EIG and $0.1 million in Corporate from acquired businesses.
Information about Company's Operations in Different Geographic Areas	Information about the Company’s operations in different geographic areas for the years ended December 31, 2024 and 2023 is shown below. 2024 2023 (In thousands) Long-lived assets from continuing operations (excluding intangible assets): United States $ 590,386 $ 646,381 International (1) : United Kingdom 68,239 73,328 European Union countries 84,707 95,781 Asia 12,416 13,351 Other foreign countries 62,863 62,452 Total international 228,225 244,912 Total consolidated $ 818,611 $ 891,293 _________________ (1) Represents long-lived assets of foreign-based operations only.

Significant Accounting Polici_4

Significant Accounting Policies - Summary Of Allowance for Credit Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at January 1	$ 13,167	$ 14,102
Bad debt expense	2,546	3,984
Amounts written off charged against allowance	(2,506)	(4,908)
Foreign currency translation and other	(175)	(11)
Balance at December 31	$ 13,032	$ 13,167

Significant Accounting Polici_5

Significant Accounting Policies - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) operation shares	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($)
Significant Accounting Policies [Line Items]
Bad debt expense	$ 2,546	$ 3,984
Percentage of LIFO method of inventory in total inventory	10%
Excess of the FIFO value over the LIFO value	$ 40,800	39,000
Depreciation expense	$ 135,300	122,500	$ 113,700
Number of operating groups | operation	2
Research and development costs	$ 236,600	220,800	198,800
Shipping and handling costs	$ 4,464,713	$ 4,212,485	4,005,261
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | shares	0	0
Shipping and Handling
Significant Accounting Policies [Line Items]
Shipping and handling costs	$ 87,600	$ 77,900	$ 103,700
Patents and Technology
Significant Accounting Policies [Line Items]
Weighted average life	15 years
Patents and Technology | Minimum
Significant Accounting Policies [Line Items]
Useful life	9 years
Patents and Technology | Maximum
Significant Accounting Policies [Line Items]
Useful life	20 years
Customer Relationship
Significant Accounting Policies [Line Items]
Weighted average life	20 years
Customer Relationship | Minimum
Significant Accounting Policies [Line Items]
Useful life	10 years
Customer Relationship | Maximum
Significant Accounting Policies [Line Items]
Useful life	20 years
Machinery and Equipment | Minimum
Significant Accounting Policies [Line Items]
Range of lives for depreciable assets, maximum	3 years
Machinery and Equipment | Maximum
Significant Accounting Policies [Line Items]
Range of lives for depreciable assets, maximum	10 years
Leasehold Improvements | Minimum
Significant Accounting Policies [Line Items]
Range of lives for depreciable assets, maximum	5 years
Leasehold Improvements | Maximum
Significant Accounting Policies [Line Items]
Range of lives for depreciable assets, maximum	27 years
Building | Minimum
Significant Accounting Policies [Line Items]
Range of lives for depreciable assets, maximum	25 years
Building | Maximum
Significant Accounting Policies [Line Items]
Range of lives for depreciable assets, maximum	50 years

Significant Accounting Polici_6

Significant Accounting Policies - Number of Weighted Average Shares (Detail) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Weighted average shares:
Basic shares (in shares)	231,256	230,519	230,208
Equity-based compensation plans (in shares)	912	990	1,328
Diluted shares (in shares)	232,168	231,509	231,536

Revenues - Outstanding Contract

Revenues - Outstanding Contract Asset and (Liability) Accounts (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Contract assets	$ 136,432	$ 140,826	$ 119,741
Change in contract assets – (decrease) increase	(4,394)	21,085
Contract liabilities	400,689	432,830	$ 398,692
Change in contract liabilities – decrease (increase)	32,141	(34,138)
Net change	$ 27,747	$ (13,053)

Revenues - Additional Informati

Revenues - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Revenue recognized from contract liabilities	$ 359	$ 345
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, remaining performance obligation		$ 607.5
Expected timing of satisfaction, period		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, remaining performance obligation	$ 541.8
Expected timing of satisfaction, period	1 year
Minimum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Expected timing of satisfaction, period	2 years
Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Expected timing of satisfaction, period	3 years
Other Noncurrent Liabilities
Customer advanced payments	$ 37.1	$ 57.3

Revenues - Information about Op

Revenues - Information about Operations in Different Geographic Areas (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Net Sales	$ 6,941,180	$ 6,596,950	$ 6,150,530
United States
Segment Reporting Information [Line Items]
Net Sales	3,649,434	3,468,784	3,154,263
United Kingdom
Segment Reporting Information [Line Items]
Net Sales	233,524	214,488	210,456
European Union countries
Segment Reporting Information [Line Items]
Net Sales	976,685	944,977	930,808
Asia
Segment Reporting Information [Line Items]
Net Sales	1,432,173	1,378,128	1,316,854
Other foreign countries
Segment Reporting Information [Line Items]
Net Sales	649,364	590,573	538,149
International
Segment Reporting Information [Line Items]
Net Sales	3,291,746	3,128,166	2,996,267
Non-US
Segment Reporting Information [Line Items]
Net Sales	1,880,800	1,732,400	1,688,700
EIG
Segment Reporting Information [Line Items]
Net Sales	4,659,915	4,624,250	4,229,353
EIG | United States
Segment Reporting Information [Line Items]
Net Sales	2,302,951	2,377,316	2,171,684
EIG | United Kingdom
Segment Reporting Information [Line Items]
Net Sales	106,678	99,718	92,668
EIG | European Union countries
Segment Reporting Information [Line Items]
Net Sales	549,446	518,758	510,052
EIG | Asia
Segment Reporting Information [Line Items]
Net Sales	1,213,403	1,175,703	1,050,843
EIG | Other foreign countries
Segment Reporting Information [Line Items]
Net Sales	487,437	452,755	404,106
EIG | International
Segment Reporting Information [Line Items]
Net Sales	2,356,964	2,246,934	2,057,669
EMG
Segment Reporting Information [Line Items]
Net Sales	2,281,265	1,972,700	1,921,177
EMG | United States
Segment Reporting Information [Line Items]
Net Sales	1,346,483	1,091,468	982,579
EMG | United Kingdom
Segment Reporting Information [Line Items]
Net Sales	126,846	114,770	117,788
EMG | European Union countries
Segment Reporting Information [Line Items]
Net Sales	427,239	426,219	420,756
EMG | Asia
Segment Reporting Information [Line Items]
Net Sales	218,770	202,425	266,011
EMG | Other foreign countries
Segment Reporting Information [Line Items]
Net Sales	161,927	137,818	134,043
EMG | International
Segment Reporting Information [Line Items]
Net Sales	$ 934,782	$ 881,232	$ 938,598

Revenues - Major Products and S

Revenues - Major Products and Services in Reportable Segments (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Net Sales	$ 6,941,180	$ 6,596,950	$ 6,150,530
Process and analytical instrumentation
Disaggregation of Revenue [Line Items]
Net Sales	3,232,918	3,267,698	3,061,263
Aerospace and power
Disaggregation of Revenue [Line Items]
Net Sales	2,051,567	1,944,998	1,717,825
Automation and engineered solutions
Disaggregation of Revenue [Line Items]
Net Sales	1,656,695	1,384,254	1,371,442
EIG
Disaggregation of Revenue [Line Items]
Net Sales	4,659,915	4,624,250	4,229,353
EIG | Process and analytical instrumentation
Disaggregation of Revenue [Line Items]
Net Sales	3,232,918	3,267,698	3,061,263
EIG | Aerospace and power
Disaggregation of Revenue [Line Items]
Net Sales	1,426,997	1,356,552	1,168,090
EIG | Automation and engineered solutions
Disaggregation of Revenue [Line Items]
Net Sales	0	0	0
EMG
Disaggregation of Revenue [Line Items]
Net Sales	2,281,265	1,972,700	1,921,177
EMG | Process and analytical instrumentation
Disaggregation of Revenue [Line Items]
Net Sales	0	0	0
EMG | Aerospace and power
Disaggregation of Revenue [Line Items]
Net Sales	624,570	588,446	549,735
EMG | Automation and engineered solutions
Disaggregation of Revenue [Line Items]
Net Sales	$ 1,656,695	$ 1,384,254	$ 1,371,442

Revenues - Timing of Revenue Re

Revenues - Timing of Revenue Recognition (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Net Sales	$ 6,941,180	$ 6,596,950	$ 6,150,530
Products transferred at a point in time
Disaggregation of Revenue [Line Items]
Net Sales	5,792,071	5,603,650	5,151,676
Products and services transferred over time
Disaggregation of Revenue [Line Items]
Net Sales	1,149,109	993,300	998,854
EIG
Disaggregation of Revenue [Line Items]
Net Sales	4,659,915	4,624,250	4,229,353
EIG | Products transferred at a point in time
Disaggregation of Revenue [Line Items]
Net Sales	3,739,209	3,831,321	3,471,118
EIG | Products and services transferred over time
Disaggregation of Revenue [Line Items]
Net Sales	920,706	792,929	758,235
EMG
Disaggregation of Revenue [Line Items]
Net Sales	2,281,265	1,972,700	1,921,177
EMG | Products transferred at a point in time
Disaggregation of Revenue [Line Items]
Net Sales	2,052,862	1,772,329	1,680,558
EMG | Products and services transferred over time
Disaggregation of Revenue [Line Items]
Net Sales	$ 228,403	$ 200,371	$ 240,619

Revenues - Changes in Accrued P

Revenues - Changes in Accrued Product Warranty Obligation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at the beginning of the year	$ 37,087	$ 26,487	$ 27,478
Accruals for warranties issued during the year	24,775	23,308	11,414
Settlements made during the year	(22,953)	(14,219)	(11,835)
Warranty accruals related to acquired businesses and other during the year	(354)	1,511	(570)
Balance at the end of the year	$ 38,555	$ 37,087	$ 26,487

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Assets Measured on Recurring Basis (Detail) - Recurring - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund investments	$ 9,124	$ 11,922
Foreign currency forward contracts	0	2,035
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund investments	9,124	11,922
Foreign currency forward contracts	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund investments	0	0
Foreign currency forward contracts	0	2,035
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual fund investments	0	0
Foreign currency forward contracts	$ 0	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) $ in Thousands, € in Millions	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2023 EUR (€)
Recurring
Derivative [Line Items]
Foreign currency forward contracts	$ 0	$ 2,035
Level 3 | Recurring
Derivative [Line Items]
Foreign currency forward contracts	0	0
Long-term debt, fair value	(1,778,700)	(2,087,600)
Reported Value Measurement
Derivative [Line Items]
Long-term debt, fair value	$ (1,851,900)	$ (2,197,500)
Euro Forward Contract
Derivative [Line Items]
Foreign currency forward contracts | €			€ 50

Hedging Activities - Additional

Hedging Activities - Additional Information (Detail) - Foreign Exchange Contract - Designated as Hedging Instrument - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
Percentage of effectiveness on net investment hedges	100%
Currency remeasurement gains (losses)	$ 45.6	$ 32.8
British-Pound-Denominated Loans
Derivative [Line Items]
Hedge against net investment in foreign subsidiaries	281.7	286.6
Euro Loan
Derivative [Line Items]
Hedge against net investment in foreign subsidiaries	$ 595.2	$ 580.8

Acquisitions - Additional Infor

Acquisitions - Additional Information (Detail) $ in Thousands, € in Millions	1 Months Ended			12 Months Ended
	Jan. 31, 2025 EUR (€)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Business Acquisition [Line Items]
Purchases of businesses, net of cash acquired				$ 117,514	$ 2,237,910	$ 429,714
Purchase price allocation adjustments and other				92,400	24,800
Total
Business Acquisition [Line Items]
Purchases of businesses, net of cash acquired				117,500
Other intangible assets		$ 60,000		60,000
Finite-lived intangible assets acquired				50,400
Future amortization expense, year one		3,000		3,000
Future amortization expense, year two		3,000		3,000
Future amortization expense, year three		3,000		3,000
Future amortization expense, year four		3,000		3,000
Future amortization expense, year five		3,000		3,000
Total | Trade Names
Business Acquisition [Line Items]
Indefinite-lived intangible trade names acquired				9,600
Total | Customer Relationship
Business Acquisition [Line Items]
Finite-lived intangible assets acquired				$ 40,800
Total | Customer Relationship | Maximum
Business Acquisition [Line Items]
Amortization period for finite-lived intangible asset				17 years
Total | Purchased technology
Business Acquisition [Line Items]
Finite-lived intangible assets acquired				$ 9,600
Amortization period for finite-lived intangible asset				5 years
Total | Purchased technology | Maximum
Business Acquisition [Line Items]
Amortization period for finite-lived intangible asset				17 years
Paragon Medical
Business Acquisition [Line Items]
Purchase price allocation adjustments and other		969,200	$ 62,200
Decrease in fixed assets		169,000	42,400
Decrease in intangibles		$ 852,300	$ 21,700
2022 Consolidated Acquisition
Business Acquisition [Line Items]
Purchases of businesses, net of cash acquired					$ 2,237,900
2021 Consolidated Acquisition
Business Acquisition [Line Items]
Purchases of businesses, net of cash acquired						$ 429,700
Kern Microtechnik | Subsequent Event
Business Acquisition [Line Items]
Business acquisition, estimated annual sales | €	€ 50

Acquisitions - Allocation of Ag

Acquisitions - Allocation of Aggregate Purchase Price of Acquired Net Assets (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill	$ 6,555,877	$ 6,447,629	$ 5,372,600
Purchases of businesses, net of cash acquired	117,514	$ 2,237,910	$ 429,714
Total
Business Acquisition [Line Items]
Goodwill	70,700
Other intangible assets	60,000
Deferred income taxes	(15,900)
Net working capital and other	2,700
Purchases of businesses, net of cash acquired	117,500
Accounts receivable included in purchase price	$ 6,600

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Changes in Carrying Amounts of Goodwill by Segment (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 6,447,629	$ 5,372,600
Goodwill acquired	70,700	1,011,700
Purchase price allocation adjustments and other	92,400	24,800
Foreign currency translation adjustments	(54,800)	38,500
Goodwill, ending balance	6,555,877	6,447,629
EIG
Goodwill [Roll Forward]
Goodwill, beginning balance	4,365,000	4,236,100
Goodwill acquired	70,700	79,300
Purchase price allocation adjustments and other	30,700	24,800
Foreign currency translation adjustments	(41,500)	24,800
Goodwill, ending balance	4,424,900	4,365,000
EMG
Goodwill [Roll Forward]
Goodwill, beginning balance	2,082,600	1,136,500
Goodwill acquired	0	932,400
Purchase price allocation adjustments and other	61,700	0
Foreign currency translation adjustments	(13,300)	13,700
Goodwill, ending balance	$ 2,131,000	$ 2,082,600

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Other Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Definite-lived intangible assets (subject to amortization)	$ 4,685,038	$ 4,704,796
Accumulated amortization	(1,793,173)	(1,563,240)
Net intangible assets subject to amortization	2,891,865	3,141,556
Total	3,915,173	4,165,317
Trademarks and trade names
Finite-Lived Intangible Assets [Line Items]
Trademarks and trade names	1,023,308	1,023,761
Patents
Finite-Lived Intangible Assets [Line Items]
Definite-lived intangible assets (subject to amortization)	46,043	47,239
Accumulated amortization	(37,977)	(38,105)
Purchased technology
Finite-Lived Intangible Assets [Line Items]
Definite-lived intangible assets (subject to amortization)	815,088	914,100
Accumulated amortization	(378,102)	(334,229)
Customer lists
Finite-Lived Intangible Assets [Line Items]
Definite-lived intangible assets (subject to amortization)	3,823,907	3,743,457
Accumulated amortization	$ (1,377,094)	$ (1,190,906)

Goodwill and Intangible Assets

Goodwill and Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 247.7	$ 215.1	$ 205.8
Future amortization expense, year one	256
Future amortization expense, year two	256
Future amortization expense, year three	256
Future amortization expense, year four	256
Future amortization expense, year five	$ 256

Other Consolidated Balance Sh_3

Other Consolidated Balance Sheet Information - Other Consolidated Balance Sheet Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
INVENTORIES, NET
Finished goods and parts	$ 80,491	$ 136,003
Work in process	171,084	165,914
Raw materials and purchased parts	770,138	830,554
Total inventories	1,021,713	1,132,471
PROPERTY, PLANT AND EQUIPMENT, NET
Land	67,640	67,195
Buildings	449,314	455,015
Machinery and equipment	1,443,288	1,479,702
Property, plant and equipment, gross	1,960,242	2,001,912
Less: Accumulated depreciation	(1,141,631)	(1,110,619)
Property, plant and equipment, Net	818,611	891,293
ACCRUED LIABILITIES AND OTHER
Employee compensation and benefits	202,605	228,389
Product warranty obligation	38,555	37,087	$ 26,487	$ 27,478
Realignment	55,175	41,540
Short term lease liability	54,736	61,055
Other	121,855	134,919
Total accrued liabilities	$ 472,926	$ 502,990

Income Taxes - Components of In

Income Taxes - Components of Income before Income Taxes and Details of Provision for Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income before income taxes:
Domestic	$ 991,681	$ 1,026,113	$ 893,478
Foreign	669,858	580,299	535,214
Income before Income Taxes	1,661,539	1,606,412	1,428,692
Current:
Federal	120,367	206,477	183,619
Foreign	155,055	144,476	119,148
State	22,936	34,173	34,201
Total current	298,358	385,126	336,968
Deferred:
Federal	(437)	(69,956)	(37,810)
Foreign	(14,317)	(15,113)	(20,818)
State	1,811	(6,833)	(9,190)
Total deferred	(12,943)	(91,902)	(67,818)
Total provision	$ 285,415	$ 293,224	$ 269,150

Income Taxes - Components of De

Income Taxes - Components of Deferred Tax Asset and Liability (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Noncurrent deferred tax asset liability
Net operating loss carryforwards	$ (116,600)
Unremitted earnings	235,800	$ 385,400
Deferred tax liabilities, gross	731,584	745,638
Less: Valuation allowance	21,305	16,766
Deferred tax liabilities, net	752,889	762,404
Portion included in non-current assets	78,141	74,291
Gross non-current deferred tax liability	831,030	836,695
Cumulative Effect, Period of Adoption, Adjustment
Noncurrent deferred tax asset liability
Deferred tax asset net	48,800	49,600
Non Current
Noncurrent deferred tax asset liability
Differences in basis of property and accelerated depreciation	49,513	63,447
Reserves not currently deductible	(117,420)	(130,761)
Pensions	89,508	75,834
Differences in basis of intangible assets and accelerated amortization	849,768	880,666
Net operating loss carryforwards	(116,611)	(109,065)
Share-based compensation	(14,614)	(14,296)
Foreign Tax Credit Carryforwards	(2,840)	(9,327)
Unremitted earnings	13,906	15,033
Other	$ (19,626)	$ (25,893)

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Effective Tax Rate to U.S. Federal Statutory Rate (Detail)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S. Federal statutory rate	21%	21%	21%
State income taxes, net of federal income tax benefit	1.40%	1.30%	1.60%
Foreign operations, net	0.50%	0.40%	(1.00%)
U.S. Benefits for Manufacturing, Export and credits	(3.40%)	(3.20%)	(2.90%)
Uncertain Tax Items	(1.90%)	1%	1%
Stock compensation	(0.50%)	(0.60%)	(0.90%)
U.S. Tax / (Benefit) on Foreign Earnings	(0.30%)	(2.00%)	(0.50%)
Other	0.40%	0.40%	0.50%
Consolidated effective tax rate	17.20%	18.30%	18.80%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Tax Credit Carryforward [Line Items]
Accrued income taxes, noncurrent	$ 15,200
Foreign earnings repatriated	1,400,000
Unremitted earnings	235,800	$ 385,400
Deferred income taxes	831,030	836,695
Net operating loss carryforwards	116,600
Income tax benefit	5,600
Tax benefits related to tax credit carryforwards	13,600
Operating loss carryforwards, interest expense limitation		13,200
Reduction in valuation allowance	4,500
Gross unrecognized tax benefits	201,600	233,500	$ 174,700	$ 147,000
The total amount of unrecognized tax benefits that would impact tax rate, if recognized	158,200	185,200
Interest and penalties accrued related to uncertain tax positions	15,300	18,300
Unrecognized tax expense (benefit), income tax penalties and interest	3,000	5,900
Additions of tax, interest and penalties related to uncertain tax positions	65,500	75,500
Tax and interest related to statute expirations and settlement of prior uncertain positions reversed	100,500	10,700
Decrease in deferred liabilities	31,900
Increase of income tax expense	25,600
Amount of tax, interest and penalties classified as a noncurrent liability	212,800
Decrease in deferred tax assets	4,200
Non-Depreciable UK Fixed Assets
Tax Credit Carryforward [Line Items]
Reduction in valuation allowance	5,300
Foreign
Tax Credit Carryforward [Line Items]
Deferred income taxes	27,400
Deferred income taxes	13,900	15,000
Operating loss carryforwards	107,400
Tax credit carryforwards	2,900	$ 1,500
Tax credit carryforwards valuation allowance	500
Federal
Tax Credit Carryforward [Line Items]
Operating loss carryforwards	200
State and Local Jurisdiction
Tax Credit Carryforward [Line Items]
Operating loss carryforwards	9,000
Operating loss carryforwards valuation allowance	3,000
Tax credit carryforwards	9,200
Tax credit carryforwards valuation allowance	$ 8,000

Income Taxes - Reconciliation_2

Income Taxes - Reconciliation of Liability for Uncertain Tax Positions (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Unrecognized Tax Benefits [Roll Forward]
Balance at the beginning of the year	$ 233.5	$ 174.7	$ 147
Additions for tax positions related to the current year	37.2	32.1	29.3
Additions for tax positions of prior years	18.1	34	2.1
Reductions for tax positions of prior years	(22.8)	(0.6)	(1)
Reductions related to settlements with taxing authorities	(1.3)	(0.1)	(0.2)
Reductions due to statute expirations	(63.1)	(6.6)	(2.5)
Balance at the end of the year	$ 201.6	$ 233.5	$ 174.7

Debt - Long-term Debt (Detail)

Debt - Long-term Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Oct. 31, 2016	Aug. 31, 2015	Jun. 30, 2015	Sep. 30, 2014
Debt Instrument [Line Items]
Less: Debt issuance costs	$ (4,058)	$ (5,724)
Total debt, net	2,079,721	3,313,347
Less: Current portion, net	(654,346)	(1,417,915)
Total long-term debt, net	1,425,375	1,895,432
Interest rate on senior notes			1.53%
U.S. dollar 3.73% senior notes due September 2024
Debt Instrument [Line Items]
Total debt, gross	$ 0	300,000
Interest rate on senior notes	3.73%					3.73%
U.S. dollar 3.91% senior notes due June 2025
Debt Instrument [Line Items]
Total debt, gross	$ 50,000	50,000
Interest rate on senior notes	3.91%				3.91%
U.S. dollar 3.96% senior notes due August 2025
Debt Instrument [Line Items]
Total debt, gross	$ 100,000	100,000
Interest rate on senior notes	3.96%			3.96%
U.S. dollar 4.18% senior notes due December 2025
Debt Instrument [Line Items]
Total debt, gross	$ 275,000	275,000
Interest rate on senior notes	4.18%
U.S. dollar 3.83% senior notes due September 2026
Debt Instrument [Line Items]
Total debt, gross	$ 100,000	100,000
Interest rate on senior notes	3.83%					3.83%
U.S. dollar 4.32% senior notes due December 2027
Debt Instrument [Line Items]
Total debt, gross	$ 250,000	250,000
Interest rate on senior notes	4.32%
U.S. dollar 4.37% senior notes due December 2028
Debt Instrument [Line Items]
Total debt, gross	$ 50,000	50,000
Interest rate on senior notes	4.37%
U.S. dollar 3.98% senior notes due September 2029
Debt Instrument [Line Items]
Total debt, gross	$ 100,000	100,000
Interest rate on senior notes	3.98%					3.98%
U.S. dollar 4.45% senior notes due August 2035
Debt Instrument [Line Items]
Total debt, gross	$ 50,000	50,000
Interest rate on senior notes	4.45%			4.45%
British pound 2.59% senior note due November 2028
Debt Instrument [Line Items]
Total debt, gross	$ 187,803	191,076
Interest rate on senior notes	2.59%
British pound 2.70% senior note due November 2031
Debt Instrument [Line Items]
Total debt, gross	$ 93,917	95,543
Interest rate on senior notes	2.70%
Euro 1.34% senior notes due October 2026
Debt Instrument [Line Items]
Total debt, gross	$ 310,514	331,770
Interest rate on senior notes	1.34%
Euro 1.71% senior notes due December 2027
Debt Instrument [Line Items]
Total debt, gross	$ 77,628	82,945
Interest rate on senior notes	1.71%
Euro 1.53% senior notes due October 2028
Debt Instrument [Line Items]
Total debt, gross	$ 207,011	221,203
Interest rate on senior notes	1.53%
Revolving credit facility borrowings
Debt Instrument [Line Items]
Total debt, gross	$ 230,000	1,116,000
Other, principally foreign
Debt Instrument [Line Items]
Total debt, gross	$ 1,906	$ 5,534

Debt - Additional Information (

Debt - Additional Information (Detail)

1 Months Ended

12 Months Ended

Jan. 06, 2025 USD ($)

Jan. 21, 2019 USD ($)

Dec. 31, 2024 USD ($)

Dec. 31, 2018 USD ($)

Dec. 31, 2018 EUR (€)

Dec. 31, 2023 USD ($)

Dec. 31, 2018 EUR (€)

Nov. 30, 2016 GBP (£)

Oct. 31, 2016 EUR (€)

Aug. 31, 2015 USD ($)

Jun. 30, 2015 USD ($)

Sep. 30, 2014 USD ($)

Debt Instrument [Line Items]

Maturities of long-term debt outstanding year one

$ 410,500,000

Maturities of long-term debt outstanding year two

327,600,000

Maturities of long-term debt outstanding year three

444,800,000

Maturities of long-term debt outstanding year four

100,000,000

$ 300,000,000

Maturities of long-term debt outstanding year five

0

Maturities of long-term debt outstanding thereafter

$ 142,500,000

Interest rate on senior notes

1.53%

Debt instrument, face amount | €

€ 200,000,000

Revolving credit facility expiration period

5 years

Weighted average interest rate on total debt borrowings outstanding

3.40%

4.20%

Revolving Credit Facility Borrowings

Debt Instrument [Line Items]

Total borrowing capacity under revolving credit facility

$ 2,300,000,000

$ 1,500,000,000

Additional borrowing capacity under revolving credit facility

700,000,000

Available borrowing capacity under revolving credit facility

2,020,300,000

Borrowings outstanding

$ 230,000,000

$ 1,116,000,000

Percentage of weighted average interest rate on revolving credit facility

6.31%

6.22%

Revolving Credit Facility Borrowings | Subsequent Event

Debt Instrument [Line Items]

Total borrowing capacity under revolving credit facility

$ 2,300,000,000

Revolving Credit Facility Borrowings | Letter of Credit

Debt Instrument [Line Items]

Borrowings outstanding

$ 49,700,000

$ 54,700,000

Accordion Feature

Debt Instrument [Line Items]

Available borrowing capacity under revolving credit facility

700,000,000

Foreign Subsidiaries

Debt Instrument [Line Items]

Available borrowing capacity under revolving credit facility

75,600,000

73,800,000

Borrowings outstanding

1,900,000

$ 5,500,000

Commercial Paper | Subsequent Event

Debt Instrument [Line Items]

Total borrowing capacity under revolving credit facility

$ 2,300,000,000

Debt instrument, term

364 days

Senior Notes

Debt Instrument [Line Items]

Debt instrument, face amount

$ 575,000,000

€ 75,000,000

Proceeds from funding

$ 100,000,000

77,600,000

$ 475,000,000

€ 75,000,000

Weighted average interest rate

3.93%

3.93%

Senior Notes | 1.34% Due October 2026

Debt Instrument [Line Items]

Interest rate on senior notes

1.34%

Debt instrument, face amount

310,500,000

€ 300,000,000

Senior Notes | 1.53% Due October 2028

Debt Instrument [Line Items]

Debt instrument, face amount

207,000,000

Senior Notes | 2.59% Due November 2028

Debt Instrument [Line Items]

Interest rate on senior notes

2.59%

Debt instrument, face amount

187,800,000

£ 150,000,000

Senior Notes | 2.70% Due November 2031

Debt Instrument [Line Items]

Interest rate on senior notes

2.70%

Debt instrument, face amount

93,900,000

£ 75,000,000

Senior Notes | U.S. dollar 3.73% senior notes due September 2024

Debt Instrument [Line Items]

Repayments of debt

$ 300,000,000

Interest rate on senior notes

3.73%

U.S. dollar 3.73% senior notes due September 2024

Debt Instrument [Line Items]

Interest rate on senior notes

3.73%

3.73%

U.S. dollar 3.83% senior notes due September 2026

Debt Instrument [Line Items]

Interest rate on senior notes

3.83%

3.83%

Debt instrument, face amount

$ 100,000,000

U.S. dollar 3.98% senior notes due September 2029

Debt Instrument [Line Items]

Interest rate on senior notes

3.98%

3.98%

U.S. dollar 3.91% senior notes due June 2025

Debt Instrument [Line Items]

Interest rate on senior notes

3.91%

3.91%

Debt instrument, face amount

$ 50,000,000

U.S. dollar 3.96% senior notes due August 2025

Debt Instrument [Line Items]

Interest rate on senior notes

3.96%

3.96%

Debt instrument, face amount

$ 100,000,000

U.S. dollar 4.45% senior notes due August 2035

Debt Instrument [Line Items]

Interest rate on senior notes

4.45%

4.45%

Debt instrument, face amount

$ 50,000,000

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		12 Months Ended
	Jan. 01, 2018	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value of stock options exercised		$ 73.5	$ 54.9	$ 50.3
Total fair value of stock options vested		$ 14.9	12.8	11.4
Beginning in 2018 Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual term of stock options		10 years
Restricted Stock Granted Prior Date
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cliff vesting period		4 years
Non Employee Directors Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cliff vesting period		2 years
Performance Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected future pre-tax compensation expense, nonvested stock options		$ 5
Nonvested stock options outstanding		0.2
Weighted average period to recognize expected future pre-tax compensation expense (in years)		1 year
Weighted average fair value, per share		$ 167.79
Performance Restricted Stock Units | Officers And Key Management Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cliff vesting period		3 years
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested stock options outstanding		0.3
Weighted average period to recognize expected future pre-tax compensation expense (in years)		2 years
Total fair value of vested restricted stock		$ 20	$ 20.5	$ 17.7
Expected future pre-tax compensation expense, nonvested restricted shares		$ 27
Weighted average fair value, per share		$ 181.74	$ 139.08
Restricted Stock | Stock Options Granted Prior Date
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, vesting rate	33.33%
Restricted Stock | Beginning in 2018 Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, vesting rate	33.33%
Restricted Stock | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, vesting rate	33.33%
Non Vested Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected future pre-tax compensation expense, nonvested stock options		$ 16
Nonvested stock options outstanding		0.6
Weighted average period to recognize expected future pre-tax compensation expense (in years)		2 years
Non Vested Restricted Stock | Stock Options Granted Prior Date
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, vesting rate	33.33%	25%
Non Vested Restricted Stock | Beginning in 2018 Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, vesting rate	33.33%	25%
Non Vested Restricted Stock | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, vesting rate	33.33%	25%
Non Vested Restricted Stock | Share-based Payment Arrangement, Tranche Four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, vesting rate		25%
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Consecutive trading days		5 days
Minimum | Performance Restricted Stock Units | Officers And Key Management Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, vesting rate		0%
Maximum | Performance Restricted Stock Units | Officers And Key Management Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, vesting rate		200%

Share-Based Compensation - Tota

Share-Based Compensation - Total Share-Based Compensation Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock option expense	$ 13,892	$ 14,284	$ 13,021
Restricted stock expense	20,422	20,792	20,115
PRSU expense	13,549	11,123	14,239
Total pre-tax expense	$ 47,863	$ 46,199	$ 47,375

Share-Based Compensation - Weig

Share-Based Compensation - Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Expected volatility	28.20%	26%	24.50%
Expected term (years)	5 years	5 years	5 years
Risk-free interest rate	4.31%	3.54%	2.33%
Expected dividend yield	0.62%	0.72%	0.65%
Black-Scholes-Merton fair value per stock option granted (in USD per share)	$ 56.42	$ 38.11	$ 32.54

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Stock Option Activity and Related Information (Detail) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares
Shares
Outstanding at the beginning of the year (in shares) | shares	2,741
Granted (in shares) | shares	231
Exercised (in shares) | shares	(779)
Forfeited (in shares) | shares	(53)
Outstanding at the end of the year (in shares) | shares	2,140
Exercisable at the end of the year (in shares) | shares	1,514
Weighted Average Exercise Price
Weighted average exercise price, Outstanding at the beginning of the year (in USD per share) | $ / shares	$ 101.20
Weighted average exercise price, Granted (in USD per share) | $ / shares	181.93
Weighted average exercise price, Exercised (in USD per share) | $ / shares	85.77
Weighted average exercise price, Forfeited (in USD per share) | $ / shares	150
Weighted average exercise price, Outstanding at the end of the year (in USD per share) | $ / shares	114.33
Weighted average exercise price, Exercisable at the end of the year (in USD per share) | $ / shares	$ 98.55
Weighted Average Remaining Contractual Life
Weighted average remaining contractual life, Outstanding at the end of the year (in years)	6 years 6 months
Weighted average remaining contractual life, Exercisable at the end of the year (in years)	5 years 8 months 12 days
Aggregate Intrinsic Value
Aggregate intrinsic value, Outstanding at the end of the year | $	$ 141.4
Aggregate intrinsic value, Exercisable at the end of the year | $	$ 123.7

Share-Based Compensation - Su_2

Share-Based Compensation - Summary of Nonvested Stock Option Activity and Related Information (Detail) - Stock Option shares in Thousands	12 Months Ended
	Dec. 31, 2024 $ / shares shares
Shares
Non-vested stock options outstanding at the beginning of the year (in shares) | shares	910
Nonvested stock options, granted (in shares) | shares	231
Nonvested stock options, Vested (in shares) | shares	(462)
Nonvested stock options, Forfeited (in shares) | shares	(53)
Non-vested stock options outstanding at the end of the year (in shares) | shares	626
Weighted Average Grant Date Fair Value
Non-vested stock options outstanding at the beginning of the year, weighted average grant date fair value (in USD per share) | $ / shares	$ 34.98
Weighted average grant date fair value, Granted (in USD per share) | $ / shares	56.42
Weighted average grant date fair value, Vested (in USD per share) | $ / shares	32.26
Weighted average grant date fair value, Forfeited (in USD per share) | $ / shares	44.68
Non-vested stock options outstanding at the the end of the year, weighted average grant date fair value (in USD per share) | $ / shares	$ 44.32

Share-Based Compensation - Su_3

Share-Based Compensation - Summary of Nonvested Restricted Stock Activity and Related Information (Detail) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Shares
Performance assumption change (in shares)	24
Weighted Average Grant Date Fair Value
Performance assumption change (in USD per share)	$ 121.91
Restricted Shares
Shares
Non-vested restricted stock outstanding at the beginning of the year (in shares)	296
Nonvested restricted stock, Granted (in shares)	149
Nonvested restricted stock, Vested (in shares)	(141)
Nonvested restricted stock, Forfeited (in shares)	(27)
Non-vested restricted stock outstanding at the end of the year (in shares)	277	296
Weighted Average Grant Date Fair Value
Non-vested restricted stock outstanding at the beginning of the year, weighted average grant date fair value (in USD per share)	$ 135.39
Weighted average grant date fair value, Granted (in USD per share)	181.74	$ 139.08
Weighted average grant date fair value, Vested (in USD per share)	132.82
Weighted average grant date fair value, Forfeited (in USD per share)	155.27
Non-vested restricted stock outstanding at the end of the year, weighted average grant date fair value (in USD per share)	$ 159.71	$ 135.39
Performance Restricted Stock Units
Shares
Non-vested restricted stock outstanding at the beginning of the year (in shares)	239
Nonvested restricted stock, Granted (in shares)	77
Nonvested restricted stock, Vested (in shares)	(99)
Nonvested restricted stock, Forfeited (in shares)	(6)
Non-vested restricted stock outstanding at the end of the year (in shares)	235	239
Weighted Average Grant Date Fair Value
Non-vested restricted stock outstanding at the beginning of the year, weighted average grant date fair value (in USD per share)	$ 131.90
Weighted average grant date fair value, Granted (in USD per share)	167.79
Weighted average grant date fair value, Vested (in USD per share)	121.91
Weighted average grant date fair value, Forfeited (in USD per share)	155.83
Non-vested restricted stock outstanding at the end of the year, weighted average grant date fair value (in USD per share)	$ 150.92	$ 131.90

Retirement Plans and Other Po_3

Retirement Plans and Other Postretirement Benefits - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Percentage of minimum employee contributions	33%
Percentage of maximum employee contributions	100%
Percentage of employee contributions for eligible compensation, Minimum	1%
Percentage of employee contributions for eligible compensation, Maximum	8%
Defined benefit plan contributions by employer employee match	$ 1,200
Market share of treasury stock held (in shares)	200,057	232,710
Market value of treasury stock held	$ 36,100,000	$ 38,400,000
Percentage of equity securities in company common stock included in plan assets	5.80%	6.40%
Estimated future benefit payments, 2024	$ 42,900,000
Estimated future benefit payments, 2025	43,200,000
Estimated future benefit payments, 2026	43,000,000
Estimated future benefit payments, 2027	43,200,000
Estimated future benefit payments, 2028	42,800,000
Estimated future benefit payments, 2027-2031	208,100,000
Amount deferred under the compensation plan, including income earned	$ 44,500,000	$ 35,900,000
Environmental loss contingency statement of financial position extensible enumeration not disclosed flag	consolidated financial statements	consolidated financial statements
Minimum
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan estimated future employer contributions in next fiscal year	$ 7,000,000
Maximum
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan estimated future employer contributions in next fiscal year	$ 10,000,000
U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Expected long-term return on plan assets	7.46%	7.59%	6.75%
Assumed rate of return next year	7.13%
U.S. Defined Benefit Pension Plans | Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations for the U.S. and foreign benefits plans	51%
U.S. Defined Benefit Pension Plans | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations for the U.S. and foreign benefits plans	29%
U.S. Defined Benefit Pension Plans | Other Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations for the U.S. and foreign benefits plans	20%
Foreign Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Expected long-term return on plan assets	6.49%	6.41%	5.85%
Assumed rate of return next year	5.78%
Foreign Defined Benefit Pension Plans | Equity Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations for the U.S. and foreign benefits plans	23%
Foreign Defined Benefit Pension Plans | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations for the U.S. and foreign benefits plans	70%
Foreign Defined Benefit Pension Plans | Other Securities
Defined Benefit Plan Disclosure [Line Items]
Target allocations for the U.S. and foreign benefits plans	7%

Retirement Plans and Other Po_4

Retirement Plans and Other Postretirement Benefits - Net Projected Benefit Obligation and Fair Value of Plan Assets for Funded and Unfunded Defined Benefit Plans (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Change in projected benefit obligation:
Net projected benefit obligation at the beginning of the year	$ 581,730
Service cost	2,800	$ 2,820	$ 4,919
Interest cost	28,085	30,209	20,124
Net projected benefit obligation at the end of the year	537,111	581,730
Change in plan assets:
Fair value of plan assets at the beginning of the year	774,329
Fair value of plan assets at the end of the year	783,203	774,329
U.S. Defined Benefit Pension Plans
Change in plan assets:
Fair value of plan assets at the beginning of the year	599,886
Fair value of plan assets at the end of the year	617,436	599,886
U.S. Defined Benefit Pension Plans | Pension Plan
Change in projected benefit obligation:
Net projected benefit obligation at the beginning of the year	366,248	383,143
Service cost	1,177	1,205
Interest cost	18,998	20,840
Actuarial (gains) losses	(10,115)	10,229
Gross benefits paid	(30,000)	(49,169)
Net projected benefit obligation at the end of the year	346,308	366,248	383,143
Change in plan assets:
Fair value of plan assets at the beginning of the year	599,886	569,049
Actual return on plan assets	46,900	79,366
Employer contributions	650	640
Gross benefits paid	(30,000)	(49,169)
Fair value of plan assets at the end of the year	617,436	599,886	569,049
Foreign Defined Benefit Pension Plans
Change in plan assets:
Fair value of plan assets at the beginning of the year	174,443
Fair value of plan assets at the end of the year	165,767	174,443
Foreign Defined Benefit Pension Plans | Pension Plan
Change in projected benefit obligation:
Net projected benefit obligation at the beginning of the year	215,482	198,744
Service cost	1,623	1,615
Interest cost	9,087	9,369
Foreign currency translation adjustments	(5,162)	10,312
Actuarial (gains) losses	(18,872)	7,575
Expenses paid from assets	(579)	(552)
Gross benefits paid	(10,776)	(11,581)
Net projected benefit obligation at the end of the year	190,803	215,482	198,744
Change in plan assets:
Fair value of plan assets at the beginning of the year	174,443	159,592
Actual return on plan assets	(2,327)	10,132
Employer contributions	8,044	8,031
Foreign currency translation adjustments	(3,038)	8,821
Expenses paid from assets	(579)	(552)
Gross benefits paid	(10,776)	(11,581)
Fair value of plan assets at the end of the year	$ 165,767	$ 174,443	$ 159,592

Retirement Plans and Other Po_5

Retirement Plans and Other Postretirement Benefits - Accumulated Benefit Obligation ("ABO") (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	$ 341,243	$ 360,056
U.S. Defined Benefit Pension Plans | Funded plans
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	339,029	357,498
U.S. Defined Benefit Pension Plans | Unfunded plans
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	2,214	2,558
Foreign Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	190,614	215,214
Foreign Defined Benefit Pension Plans | Funded plans
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	155,368	178,854
Foreign Defined Benefit Pension Plans | Unfunded plans
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	$ 35,246	$ 36,360

Retirement Plans and Other Po_6

Retirement Plans and Other Postretirement Benefits - Weighted Average Assumptions Used to Determine Benefit Obligations (Detail) - Pension Plan	Dec. 31, 2024	Dec. 31, 2023
U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Discount rate	5.74%	5.38%
Rate of compensation increase (where applicable)	3.75%	3.75%
Foreign Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Discount rate	5.20%	4.36%
Rate of compensation increase (where applicable)	3%	3%

Retirement Plans and Other Po_7

Retirement Plans and Other Postretirement Benefits - Fair Value of Plan Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 783,203	$ 774,329
U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	617,436	599,886
Municipal bonds | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,456	1,253
Hedge Funds | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	31,900	0
Corporate debt instruments | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,595	5,295
Corporate debt instruments – Preferred | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	18,027	16,004
Corporate stocks – Common | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	56,258	43,287
Registered investment companies | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	145,380	169,794
U.S. Government securities | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,141	1,262
Total investments | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	256,757	236,895
Investments measured at net asset value | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	360,679	362,991
Level 1 | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	201,638	213,081
Level 1 | Municipal bonds | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Level 1 | Hedge Funds | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Level 1 | Corporate debt instruments | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Level 1 | Corporate debt instruments – Preferred | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Level 1 | Corporate stocks – Common | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	56,258	43,287
Level 1 | Registered investment companies | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	145,380	169,794
Level 1 | U.S. Government securities | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Level 1 | Total investments | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	201,638	213,081
Level 1 | Investments measured at net asset value | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Level 2 | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	23,219	23,814
Level 2 | Municipal bonds | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,456	1,253
Level 2 | Hedge Funds | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Level 2 | Corporate debt instruments | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,595	5,295
Level 2 | Corporate debt instruments – Preferred | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	18,027	16,004
Level 2 | Corporate stocks – Common | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Level 2 | Registered investment companies | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Level 2 | U.S. Government securities | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,141	1,262
Level 2 | Total investments | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	23,219	23,814
Level 2 | Investments measured at net asset value | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	$ 0
Level 3 | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	31,900
Level 3 | Municipal bonds | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
Level 3 | Hedge Funds | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	31,900
Level 3 | Corporate debt instruments | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
Level 3 | Corporate debt instruments – Preferred | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
Level 3 | Corporate stocks – Common | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
Level 3 | Registered investment companies | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
Level 3 | U.S. Government securities | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
Level 3 | Total investments | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	31,900
Level 3 | Investments measured at net asset value | U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 0

Retirement Plans and Other Po_8

Retirement Plans and Other Postretirement Benefits - Fair Value of Plan Assets for Foreign Defined Benefit Pension Plans (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 783,203	$ 774,329
Foreign Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	165,767	174,443
Foreign Defined Benefit Pension Plans | Life insurance
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	10,766	12,619
Foreign Defined Benefit Pension Plans | Total investments
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	10,766	12,619
Foreign Defined Benefit Pension Plans | Investments measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	155,001	161,824
Level 3 | Foreign Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	10,766	12,619
Level 3 | Foreign Defined Benefit Pension Plans | Life insurance
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	10,766	12,619	$ 13,043
Level 3 | Foreign Defined Benefit Pension Plans | Total investments
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 10,766	$ 12,619

Retirement Plans and Other Po_9

Retirement Plans and Other Postretirement Benefits - Summary of Changes of Fair Value of Foreign Plans' Investments Using Significant Unobservable Inputs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]
Fair value of plan assets at the beginning of the year	$ 774,329
Actual return on assets:
Fair value of plan assets at the end of the year	783,203	$ 774,329
U.S. Defined Benefit Pension Plans
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]
Fair value of plan assets at the beginning of the year	599,886
Actual return on assets:
Fair value of plan assets at the end of the year	617,436	599,886
Foreign Defined Benefit Pension Plans
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]
Fair value of plan assets at the beginning of the year	174,443
Actual return on assets:
Fair value of plan assets at the end of the year	165,767	174,443
Foreign Defined Benefit Pension Plans | Life insurance
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]
Fair value of plan assets at the beginning of the year	12,619
Actual return on assets:
Fair value of plan assets at the end of the year	10,766	12,619
Level 3 | U.S. Defined Benefit Pension Plans
Actual return on assets:
Fair value of plan assets at the end of the year	31,900
Level 3 | U.S. Defined Benefit Pension Plans | Hedge Funds
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]
Fair value of plan assets at the beginning of the year	0
Actual return on assets:
Unrealized losses relating to instruments still held at the end of the year	0
Realized gains (losses) relating to assets sold during the year	0
Purchases, sales, issuances and settlements, net	31,900
Fair value of plan assets at the end of the year	31,900	0
Level 3 | Foreign Defined Benefit Pension Plans
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]
Fair value of plan assets at the beginning of the year	12,619
Actual return on assets:
Fair value of plan assets at the end of the year	10,766	12,619
Level 3 | Foreign Defined Benefit Pension Plans | Life insurance
Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]
Fair value of plan assets at the beginning of the year	12,619	13,043
Actual return on assets:
Unrealized losses relating to instruments still held at the end of the year	(1,853)	(424)
Realized gains (losses) relating to assets sold during the year	0	0
Purchases, sales, issuances and settlements, net	0	0
Fair value of plan assets at the end of the year	$ 10,766	$ 12,619

Retirement Plans and Other P_10

Retirement Plans and Other Postretirement Benefits - Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets (Detail) - Pension Plan - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation exceeds fair value of assets, projected benefit obligation	$ 2,214	$ 2,558
Projected benefit obligation exceeds fair value of assets, fair value of plan assets	0	0
Accumulated benefit obligation exceeds fair value of assets, projected benefit obligation	2,214	2,558
Accumulated benefit obligation exceeds fair value of assets, fair value of plan assets	0	0
Foreign Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation exceeds fair value of assets, projected benefit obligation	35,435	132,796
Projected benefit obligation exceeds fair value of assets, fair value of plan assets	2,316	88,028
Accumulated benefit obligation exceeds fair value of assets, projected benefit obligation	35,246	132,527
Accumulated benefit obligation exceeds fair value of assets, fair value of plan assets	$ 2,316	$ 88,028

Retirement Plans and Other P_11

Retirement Plans and Other Postretirement Benefits - Funded Status of Plan and Amounts Recognized in Balance Sheet (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Funded status asset (liability):
Fair value of plan assets	$ 783,203	$ 774,329
Projected benefit obligation	(537,111)	(581,730)
Funded status at the end of the year	246,092	192,599
Amounts recognized in the consolidated balance sheet consisted of:
Non-current asset for pension benefits (other assets)	281,425	239,925
Current liabilities for pension benefits	(2,294)	(2,816)
Non-current liability for pension benefits	(33,039)	(44,510)
Net amount recognized at the end of the year	$ 246,092	$ 192,599

Retirement Plans and Other P_12

Retirement Plans and Other Postretirement Benefits - Amounts Recognized in Accumulated Other Comprehensive Income, Net of Taxes (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Total recognized	$ 163,606	$ 186,107
Net actuarial loss
Defined Benefit Plan Disclosure [Line Items]
Total recognized	162,086	184,489
Prior service costs
Defined Benefit Plan Disclosure [Line Items]
Total recognized	1,519	1,616
Transition asset
Defined Benefit Plan Disclosure [Line Items]
Total recognized	$ 1	$ 2

Retirement Plans and Other P_13

Retirement Plans and Other Postretirement Benefits - Components of Net Periodic Pension Benefit Expense (Income) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined benefit plans:
Service cost	$ 2,800	$ 2,820	$ 4,919
Interest cost	28,085	30,209	20,124
Expected return on plan assets	(54,672)	(52,289)	(60,104)
Settlement	0	0	(58)
Amortization of:
Net actuarial loss	9,619	11,569	8,531
Prior service costs	103	101	100
Transition asset	1	1	1
Total net periodic benefit income	(14,064)	(7,589)	(26,487)
Other plans:
Defined contribution plans	44,898	43,044	39,326
Foreign plans and other	8,575	9,015	8,373
Total other plans	53,473	52,059	47,699
Total net pension expense	$ 39,409	$ 44,470	$ 21,212
Defined benefit plan, net periodic benefit cost (credit) excluding service cost, statement of income or comprehensive income	Cost of sales, Other (expense) income, net, Selling, general and administrative	Cost of sales, Other (expense) income, net, Selling, general and administrative	Cost of sales, Other (expense) income, net, Selling, general and administrative

Retirement Plans and Other P_14

Retirement Plans and Other Postretirement Benefits - Weighted Average Assumptions Used to Determine Net Periodic Pension Benefit Expense (Detail)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
U.S. Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Discount rate	5.38%	5.65%	3.02%
Expected return on plan assets	7.46%	7.59%	6.75%
Rate of compensation increase (where applicable)	3.75%	3.75%	3.75%
Foreign Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Discount rate	4.36%	4.73%	1.78%
Expected return on plan assets	6.49%	6.41%	5.85%
Rate of compensation increase (where applicable)	3%	2.50%	2.50%

Contingencies - Additional Info

Contingencies - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) site	Dec. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Number of non-owned sites Company is named Potentially Responsible Party | site	13
Total environmental reserves	$ 29.8	$ 37.1
Increase (decrease) in environmental reserves	9.7
Total expenses related to environmental matters	$ 17

Leases and Other Commitments -

Leases and Other Commitments - Additional Information (Detail) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Lessee, Lease, Description [Line Items]
Weighted-average remaining lease terms – operating leases (years)	6 years 5 months 26 days	6 years 7 months 28 days
Purchase obligations outstanding	$ 761.9	$ 790
Future payment obligations	261.2
Future payment obligations, guarantees	$ 173.1
Minimum
Lessee, Lease, Description [Line Items]
Weighted-average remaining lease terms – operating leases (years)	1 month
Maximum
Lessee, Lease, Description [Line Items]
Weighted-average remaining lease terms – operating leases (years)	15 years

Leases and Other Commitments _2

Leases and Other Commitments - Components of Lease Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating lease cost	$ 76,315	$ 63,049	$ 59,296
Variable lease cost	11,730	11,384	11,096
Total lease cost	$ 88,045	$ 74,433	$ 70,392

Leases and Other Commitments _3

Leases and Other Commitments - Supplemental Balance Sheet Information Related to Leases (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Right of use assets, net	$ 235,666	$ 229,723
Operating lease, liability, current, statement of financial position	Accrued Liabilities and Other Liabilities	Accrued Liabilities and Other Liabilities
Lease liabilities included in Accrued liabilities and other	$ 54,736	$ 61,055
Operating lease, liability, noncurrent, statement of financial position	Other long-term liabilities	Other long-term liabilities
Lease liabilities included in Other long-term liabilities	$ 190,017	$ 182,436
Total lease liabilities	$ 244,753	$ 243,491

Leases and Other Commitments _4

Leases and Other Commitments - Supplemental Cash Flow Information Related to Leases (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Right-of-use assets obtained in exchange for new operating liabilities	$ 44,079	$ 95,052
Weighted-average remaining lease terms – operating leases (years)	6 years 5 months 26 days	6 years 7 months 28 days
Weighted-average discount rate – operating leases	4.74%	4.48%

Leases and Other Commitments _5

Leases and Other Commitments - Maturities of lease liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
2025	$ 61,789
2026	52,241
2027	39,654
2028	29,419
2029	23,576
Thereafter	71,426
Total lease payments	278,105
Less: imputed interest	33,352
Operating lease liability	$ 244,753	$ 243,491

Reportable Segments and Geogr_3

Reportable Segments and Geographic Areas Information - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	2

Reportable Segments and Geogr_4

Reportable Segments and Geographic Areas Information - Reportable Segment Financial Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment operating income:
Net Sales	$ 6,941,180	$ 6,596,950	$ 6,150,530
Cost of sales	4,464,713	4,212,485	4,005,261
Selling expense	591,557	576,934	551,947
Operating Income	1,779,562	1,707,459	1,500,692
Selling, general and administrative	105,348	100,072	92,630
Interest expense	(112,962)	(81,795)	(83,186)
Other (expense) income, net	(5,061)	(19,252)	11,186
Income before Income Taxes	1,661,539	1,606,412	1,428,692
Depreciation and amortization:
Depreciation	135,266	122,502	113,662
Amortization	247,661	215,134	205,765
Total depreciation and amortization	382,927	337,636	319,427
Research, Development & Engineering costs (2)	371,875	351,661	322,070
Assets:
Assets	14,631,169	15,023,533	12,431,120
Capital Expenditures	128,158	371,061	151,448
EMG
Segment operating income:
Net Sales	2,281,265	1,972,700	1,921,177
EIG
Segment operating income:
Net Sales	4,659,915	4,624,250	4,229,353
Operating Segments
Segment operating income:
Operating Income	1,884,910	1,807,531	1,593,322
Operating Segments | EMG
Segment operating income:
Net Sales	2,281,265	1,972,700	1,921,177
Cost of sales	1,736,694	1,393,086	1,337,108
Selling expense	88,070	83,045	80,476
Operating Income	456,501	496,569	503,593
Interest expense	0	0	0
Other (expense) income, net	0	0	0
Income before Income Taxes	456,501	496,569	503,593
Depreciation and amortization:
Depreciation	58,049	40,443	37,474
Amortization	74,452	43,471	40,422
Total depreciation and amortization	132,501	83,914	77,896
Research, Development & Engineering costs (2)	72,434	68,960	63,892
Assets:
Assets	4,758,856	4,957,944	2,617,685
Capital Expenditures	41,022	272,060	38,186
Operating Segments | EIG
Segment operating income:
Net Sales	4,659,915	4,624,250	4,229,353
Cost of sales	2,728,019	2,819,399	2,668,153
Selling expense	503,487	493,889	471,471
Operating Income	1,428,409	1,310,962	1,089,729
Interest expense	0	0	0
Other (expense) income, net	0	0	0
Income before Income Taxes	1,428,409	1,310,962	1,089,729
Depreciation and amortization:
Depreciation	71,351	77,344	73,093
Amortization	173,209	171,663	165,343
Total depreciation and amortization	244,560	249,007	238,436
Research, Development & Engineering costs (2)	299,441	282,701	258,178
Assets:
Assets	9,302,031	9,559,282	9,430,797
Capital Expenditures	58,859	86,616	93,505
Corporate
Segment operating income:
Operating Income	(105,348)	(100,072)	(92,630)
Selling, general and administrative	105,348	100,072	92,630
Interest expense	(112,962)	(81,795)	(83,186)
Other (expense) income, net	(5,061)	(19,252)	11,186
Income before Income Taxes	(223,371)	(201,119)	(164,630)
Depreciation and amortization:
Depreciation	5,866	4,715	3,095
Amortization	0	0	0
Total depreciation and amortization	5,866	4,715	3,095
Research, Development & Engineering costs (2)	0	0	0
Assets:
Assets	570,282	506,307	382,638
Capital Expenditures	$ 28,277	$ 12,385	$ 19,757

Reportable Segments and Geogr_5

Reportable Segments and Geographic Areas Information - Reportable Segment Financial Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating Segments
Segment Reporting Information [Line Items]
Additions to property, plant and equipment from acquired business			$ 12,300
Corporate
Segment Reporting Information [Line Items]
Additions to property, plant and equipment from acquired business			100
EMG
Segment Reporting Information [Line Items]
Integration cost	$ 29,200
Gain (Loss) on Sale of Properties			$ 7,100
Additions to property, plant and equipment from acquired business		$ 223,700
EIG
Segment Reporting Information [Line Items]
Additions to property, plant and equipment from acquired business	$ 1,100	$ 11,100

Reportable Segments and Geogr_6

Reportable Segments and Geographic Areas Information - Information about Company's Operations in Different Geographic Areas (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Long-lived assets from continuing operations (excluding intangible assets):
Long-lived assets from continuing operations (excluding intangible assets)	$ 818,611	$ 891,293
United States
Long-lived assets from continuing operations (excluding intangible assets):
Long-lived assets from continuing operations (excluding intangible assets)	590,386	646,381
United Kingdom
Long-lived assets from continuing operations (excluding intangible assets):
Long-lived assets from continuing operations (excluding intangible assets)	68,239	73,328
European Union countries
Long-lived assets from continuing operations (excluding intangible assets):
Long-lived assets from continuing operations (excluding intangible assets)	84,707	95,781
Asia
Long-lived assets from continuing operations (excluding intangible assets):
Long-lived assets from continuing operations (excluding intangible assets)	12,416	13,351
Other foreign countries
Long-lived assets from continuing operations (excluding intangible assets):
Long-lived assets from continuing operations (excluding intangible assets)	62,863	62,452
Total international
Long-lived assets from continuing operations (excluding intangible assets):
Long-lived assets from continuing operations (excluding intangible assets)	$ 228,225	$ 244,912

Additional Consolidated Incom_2

Additional Consolidated Income Statement and Cash Flow Information - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interest and other investment income	$ 6.8	$ 12	$ 1
Income taxes paid	302.2	336.2	299.3
Cash paid for interest	$ 113.9	$ 66.3	$ 80.2

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands					12 Months Ended
	Feb. 07, 2025	Feb. 06, 2025	Feb. 09, 2024	Feb. 08, 2024	Dec. 31, 2024	Dec. 31, 2023	May 31, 2022	May 05, 2022	Feb. 28, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Repurchase of common stock (in shares)					1,300,000	100,000
Repurchase of common stock under share repurchase authorization					$ 223,100	$ 7,800
Common stock, shares authorized					800,000,000	800,000,000		1,000,000,000	500,000,000
Remaining authorization for future share repurchases					$ 593,100
Percent increase in cash dividend			12%
Dividends paid per share (in dollars per share)			$ 0.28	$ 0.25
Treasury stock (in shares)					39,364,801	38,354,154
Treasury stock, cost					$ 2,114,031	$ 1,896,613
Number of shares outstanding					230,700,000	230,900,000
Share repurchase authorized amount (in shares)							$ 1,000,000
Subsequent Event
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percent increase in cash dividend	11%
Dividends paid per share (in dollars per share)	$ 0.31	$ 0.28
Share repurchase authorized amount (in shares)	$ 1,250,000